<SEC-DOCUMENT>0000950103-25-014290.txt : 20251104
<SEC-HEADER>0000950103-25-014290.hdr.sgml : 20251104
<ACCEPTANCE-DATETIME>20251104172331
ACCESSION NUMBER:		0000950103-25-014290
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		16
FILED AS OF DATE:		20251104
DATE AS OF CHANGE:		20251104

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CITIGROUP INC
		CENTRAL INDEX KEY:			0000831001
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				521568099
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327
		FILM NUMBER:		251450816

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		2125591000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH STREET
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS GROUP INC
		DATE OF NAME CHANGE:	19950519

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRAVELERS INC
		DATE OF NAME CHANGE:	19940103

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PRIMERICA CORP /NEW/
		DATE OF NAME CHANGE:	19920703

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Citigroup Global Markets Holdings Inc.
		CENTRAL INDEX KEY:			0000200245
		STANDARD INDUSTRIAL CLASSIFICATION:	SECURITY BROKERS, DEALERS & FLOTATION COMPANIES [6211]
		ORGANIZATION NAME:           	02 Finance
		EIN:				112418067
		STATE OF INCORPORATION:			NY
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-270327-01
		FILM NUMBER:		251450817

	BUSINESS ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013
		BUSINESS PHONE:		212-816-6000

	MAIL ADDRESS:	
		STREET 1:		388 GREENWICH ST
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10013

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CITIGROUP GLOBAL MARKETS HOLDINGS INC
		DATE OF NAME CHANGE:	20030404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON SMITH BARNEY HOLDINGS INC
		DATE OF NAME CHANGE:	19971128

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SALOMON INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>dp236936_424b2-us2515944d.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 53%; font-size: 10pt; color: #888888"><FONT STYLE="font-size: 18pt">Citigroup Global Markets Holdings Inc.</FONT></TD>
    <TD STYLE="width: 47%"><P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">October
    31, 2025</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Medium-Term
    Senior Notes, Series N</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Pricing
    Supplement No. 2025-USNCH28746</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Filed
    Pursuant to Rule 424(b)(2)</FONT></P>
    <P STYLE="color: gray; font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-size: 9pt">Registration
    Statement Nos. 333-270327 and 333-270327-01</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,67); margin: 0pt 0">Autocallable Contingent Coupon Equity Linked Securities
Linked to the Nasdaq-100 Futures 35% Edge Volatility 6% Decrement<SUP>&trade;</SUP> Index ER Due November 10, 2032</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>The securities offered by this pricing supplement are unsecured
debt securities issued by Citigroup Global Markets Holdings Inc. and guaranteed by Citigroup Inc. The securities offer the potential
for periodic contingent coupon payments at an annualized rate that, if all are paid, would produce a yield that is generally higher than
the yield on our conventional debt securities of the same maturity. In exchange for this higher potential yield, you must be willing
to accept the risks that (i) your actual yield may be lower than the yield on our conventional debt securities of the same maturity because
you may not receive one or more, or any, contingent coupon payments, (ii) the value of what you receive at maturity may be significantly
less than the stated principal amount of your securities, and may be zero, and (iii) the securities may be automatically called for redemption
prior to maturity on any trading day during the autocall period specified below. Each of these risks will depend on the performance of
the underlying specified below. Although you will have downside exposure to the underlying, you will not receive dividends with respect
to the underlying or participate in any appreciation of the underlying.</TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD><B>The underlying is highly risky because it may reflect highly
leveraged exposure to any decline in the Citi Equity US Tech Large Cap QX Market Tracker Series 4 Index, which we refer to as the &ldquo;underlying
futures index&rdquo;.&nbsp;&nbsp;The underlying futures index tracks futures contracts on the Nasdaq-100 Index<SUP>&reg;</SUP> and is
likely to underperform the Nasdaq-100 Index<SUP>&reg;</SUP> because of an implicit financing cost.&nbsp;&nbsp;In addition, the underlying
is subject to a decrement of 6% per annum, which will be a significant drag on its performance.&nbsp;&nbsp;Each of the underlying and
the underlying futures index is published by Citigroup Global Markets Limited, an affiliate of ours. You should carefully review the
section &ldquo;Summary Risk Factors&mdash;Summary of Key Risks Relating to the Underlying&rdquo; in this pricing supplement.</B></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">&squarf;</FONT></TD><TD>Investors in the securities must be willing to accept (i) an
investment that may have limited or no liquidity and (ii) the risk of not receiving any payments due under the securities if we and Citigroup
Inc. default on our obligations. <B>All payments on the securities are subject to the credit risk of Citigroup Global Markets Holdings
Inc. and Citigroup Inc.</B></TD>
</TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif"></P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="4"><FONT STYLE="font-size: 10pt; color: white"><B>KEY TERMS</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issuer:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Holdings Inc., a wholly owned subsidiary of Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Guarantee:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">All payments due on the securities are fully and unconditionally guaranteed by Citigroup Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underlying:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The Nasdaq-100 Futures 35% Edge Volatility 6% Decrement<SUP>&trade;</SUP> Index ER</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Stated principal amount:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">$1,000 per security</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Pricing date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">October 31, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">November 5, 2025</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Valuation dates:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The 5th day of each month, beginning in December 2025 and ending in November 2032, <I>provided</I> that the November 2032 valuation date will be November 5, 2032 (the &ldquo;final valuation date&rdquo;), each subject to postponement if such date is not a scheduled trading day or certain market disruption events occur</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Maturity date:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Unless earlier redeemed, November 10, 2032</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon payment dates:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The third business day after each valuation date, except that the contingent coupon payment date following the final valuation date will be the maturity date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Contingent coupon:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">On each contingent coupon payment date, unless previously redeemed, the securities will pay a contingent coupon equal to 1.4167% of the stated principal amount of the securities (equivalent to a contingent coupon rate of approximately 17.00% per annum) <B>if and only if</B> the closing value of the underlying on the immediately preceding valuation date is greater than or equal to the coupon barrier value. <B>If the closing value of the underlying on any valuation date is less than the coupon barrier value, you will not receive any contingent coupon payment on the immediately following contingent coupon payment date. </B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Payment at maturity:</B></FONT></TD>
    <TD COLSPAN="3">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">If the securities are not automatically redeemed prior to maturity,
you will receive at maturity for each security you then hold (in addition to the final contingent coupon payment, if applicable):</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT>&nbsp;If
the final underlying value is <B>greater than or equal to</B> the final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$1,000</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt; text-indent: -8.5pt"><FONT STYLE="font-family: Wingdings">&sect;</FONT>&nbsp;If
the final underlying value is <B>less than</B> the final barrier value:</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 26.35pt">$1,000 + ($1,000 &times; the underlying return)</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>If the securities are not automatically redeemed prior to maturity
and the final underlying value is less than the final barrier value, you will receive significantly less than the stated principal amount
of your securities, and possibly nothing, at maturity, and you will not receive any contingent coupon payment at maturity.</B></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Initial underlying value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">1,707.772, the closing value of the underlying on the pricing date</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final underlying value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The closing value of the underlying on the final valuation date</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Coupon barrier value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">1,195.440, 70.00% of the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Final barrier value:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">1,024.663, 60.00% of the initial underlying value</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Listing:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">The securities will not be listed on any securities exchange</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriter:</B></FONT></TD>
    <TD COLSPAN="3"><FONT STYLE="font-size: 10pt">Citigroup Global Markets Inc. (&ldquo;<B>CGMI</B>&rdquo;), an affiliate of the issuer, acting as principal</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD STYLE="width: 25%"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee and issue price:</B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Issue price<SUP>(1)</SUP></B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Underwriting fee<SUP>(2)</SUP></B></FONT></TD>
    <TD STYLE="width: 25%; text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Proceeds to issuer</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Per security:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$20.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$980.00</FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Total:</B></FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,777,000.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$35,540.00</FONT></TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt">$1,741,460.00</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: right"><I>(Key Terms continued on next page)</I></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">(1) On the date of this pricing supplement,
the estimated value of the securities is $911.30 per security, which is less than the issue price.&nbsp;&nbsp;The estimated value of
the securities is based on CGMI&rsquo;s proprietary pricing models and our internal funding rate. It is not an indication of actual profit
to CGMI or other of our affiliates, nor is it an indication of the price, if any, at which CGMI or any other person may be willing to
buy the securities from you at any time after issuance. See &ldquo;Valuation of the Securities&rdquo; in this pricing supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="font-size: 9pt">(2) For more information on the distribution
of the securities, see &ldquo;Supplemental Plan of Distribution&rdquo; in this pricing supplement. In addition to the underwriting fee,
CGMI and its affiliates may profit from hedging activity related to this offering, even if the value of the securities declines. See
&ldquo;Use of Proceeds and Hedging&rdquo; in the accompanying prospectus.</FONT></P>

<P STYLE="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Investing in the securities involves risks not associated with an
investment in conventional debt securities. See &ldquo;Summary Risk Factors&rdquo; beginning on page PS-6.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>Neither the Securities and Exchange Commission
(the &ldquo;SEC&rdquo;) nor any state securities commission has approved or disapproved of the securities or determined that this pricing
supplement and the accompanying product supplement, index supplement, prospectus supplement and prospectus are truthful or complete.
Any representation to the contrary is a criminal offense.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>You should read this pricing supplement together
with the accompanying product supplement, index supplement, prospectus supplement and prospectus, which can be accessed via the hyperlinks
below:</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010323003814/dp190219_424b2-coba0410.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Product
Supplement No. EA-04-10 dated March 7, 2023</B></FONT></A><FONT STYLE="font-size: 10pt">&#9;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/200245/000095010325005805/dp228591_424b2-1601.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Index
Supplement No. IS-16-01 dated May 7, 2025</B></FONT></A><FONT STYLE="font-size: 10pt"><BR>
</FONT><A HREF="https://www.sec.gov/Archives/edgar/data/831001/000119312523063080/d470905d424b2.htm" STYLE="color: rgb(89,174,67); text-decoration: underline"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Prospectus
Supplement and Prospectus each dated March 7, 2023</B></FONT></A></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>The securities are not bank deposits and are
not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of,
or guaranteed by, a bank.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->


<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD COLSPAN="2"><FONT STYLE="color: white"><B>KEY TERMS (continued)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 25%"><FONT STYLE="color: #59AE43"><B>Automatic early redemption:</B></FONT></TD>
    <TD STYLE="width: 75%">If, on any trading day during the autocall period, the closing value of the underlying is greater than or equal to the initial underlying value, each security you then hold will be automatically called for redemption on the third business day immediately following that trading day (the &ldquo;automatic early redemption date&rdquo;) for an amount in cash equal to the $1,000 stated principal amount. If the closing value of the underlying is greater than or equal to the initial underlying value on a trading day during the autocall period that is not a valuation date, you will not receive any contingent coupon payment in respect of the period from and including the immediately preceding contingent coupon payment date to but excluding the automatic early redemption date. <B>The automatic early redemption feature may significantly limit your potential return on the securities. If the underlying performs in a way that would otherwise be favorable, the securities are likely to be automatically called for redemption prior to maturity, cutting short your opportunity to receive contingent coupon payments. The securities may be automatically called for redemption as early as the first trading day during the autocall period specified below.</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="color: #59AE43"><B>Autocall period:</B></FONT></TD>
    <TD>The period from and including November 5, 2026 to but excluding the final valuation date</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: #59AE43"><B>Trading day:</B></FONT></TD>
    <TD>Any scheduled trading day other than a day on which a market disruption event occurs</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #EAF3E5">
    <TD><FONT STYLE="color: #59AE43"><B>Underlying return:</B></FONT></TD>
    <TD>(i) The final underlying value <I>minus</I> the initial underlying value, <I>divided by</I> (ii) the initial underlying value</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="color: #59AE43"><B>CUSIP / ISIN:</B></FONT></TD>
    <TD>17331BBT5 / US17331BBT52</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Information</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The terms of the securities are set forth in the accompanying product
supplement, prospectus supplement and prospectus, as supplemented by this pricing supplement.&nbsp;&nbsp;The accompanying product supplement,
prospectus supplement and prospectus contain important disclosures that are not repeated in this pricing supplement. For example, the
accompanying product supplement contains important information about how the closing value of the underlying will be determined and about
adjustments that may be made to the terms of the securities upon the occurrence of market disruption events and other specified events
with respect to the underlying. The accompanying index supplement contains information about the underlying that is not repeated in this
pricing supplement.&nbsp;&nbsp;It is important that you read the accompanying product supplement, index supplement, prospectus supplement
and prospectus together with this pricing supplement in connection with your investment in the securities. Certain terms used but not
defined in this pricing supplement are defined in the accompanying product supplement or the accompanying index supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Description of the Underlying</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The underlying is published by Citigroup Global Markets Limited, an
affiliate of ours.&nbsp;&nbsp;The underlying was first published on April 28, 2025, and therefore has a limited performance history.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The underlying tracks exposure to the Citi Equity US Tech Large Cap
QX Market Tracker Series 4 Index, which we refer to as the &ldquo;underlying futures index&rdquo;, on a volatility-targeted basis, <I>less
</I>a decrement of 6% per annum.&nbsp;&nbsp;The underlying has a volatility target of 35%, which it attempts to achieve by applying leverage
to its exposure to the underlying futures index (up to a maximum of 500%) when the implied volatility of the Nasdaq-100 Index is less
than its volatility target, and by reducing its exposure to the underlying futures index below 100% when the implied volatility of the
Nasdaq-100 Index is greater than its volatility target.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The underlying futures index is also published by Citigroup Global Markets
Limited and tracks the performance of a hypothetical investment, rolled quarterly, in futures contracts on the Nasdaq-100 Index.&nbsp;&nbsp;The
Nasdaq-100 Index, which is published by Nasdaq, Inc., is designed to measure the performance of the 100 largest non-financial companies
listed on The Nasdaq Stock Market.&nbsp;&nbsp;Because the underlying futures index tracks futures contracts on the Nasdaq-100 Index, rather
than the Nasdaq-100 Index directly, it is expected to be negatively impacted by an implicit financing cost, which is likely to cause the
underlying futures index to underperform the Nasdaq-100 Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">The methodology of the underlying
is premised on the following key assumptions: (1) that there will be an inverse relationship between performance and volatility, so that
the underlying futures index will tend to increase in times of lower volatility and decline in times of higher volatility; (2) that the
implied volatility of the Nasdaq-100 Index, as derived from the market prices of exchange-traded options on the Nasdaq-100 Index on each
weekly rebalancing date, will be an effective predictor of future volatility of the underlying futures index over the next week; and (3)
that the volatility target of the underlying will be an effective level of volatility at which to draw the line between leveraged exposure
and deleveraged exposure to the underlying futures index.&nbsp;&nbsp;If these assumptions prove to be consistently correct, then the underlying
has the potential to outperform the underlying futures index by participating in increases on a leveraged basis and declines on a deleveraged
basis.&nbsp;&nbsp;There is no guarantee, however, that these assumptions will be proven correct over any given time period.&nbsp;&nbsp;If
any of these assumptions does not prove to be consistently correct, then the underlying may perform poorly as a result of having highly
leveraged exposure to the underlying futures index at a time of declines and/or having reduced exposure to the underlying futures index
at a time of increases.&nbsp;&nbsp;The underlying may also be subject to a &ldquo;decay&rdquo; effect, which will exacerbate the decline
in the underlying that results from having highly leveraged exposure to declines in the underlying futures index, as described in more
detail in the accompanying index supplement.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">It is important to understand
that the underlying provides exposure to the </FONT>Nasdaq-100 Index <FONT STYLE="background-color: white">that:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">1.</TD><TD><FONT STYLE="background-color: white">may be leveraged up to 500%, or alternatively may reflect less than 100% participation, in an
attempt to maintain its volatility target;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">2.</TD><TD><FONT STYLE="background-color: white">is reduced by an implicit financing cost;</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">3.</TD><TD><FONT STYLE="background-color: white">may be subject to a decay effect; and</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">4.</TD><TD><FONT STYLE="background-color: white">is reduced by a decrement of 6% per annum.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">As a result of these features, the underlying may significantly underperform
the Nasdaq-100 Index.&nbsp;&nbsp;The underlying is likely to significantly underperform the Nasdaq-100 Index if it is not consistently
successful in increasing exposure to the underlying futures index in advance of increases in the underlying futures index and reducing
exposure to the underlying futures index in advance of declines in the underlying futures index.&nbsp;&nbsp;The underlying may significantly
underperform the Nasdaq-100 Index even if it is consistently successful in these respects because of the implicit financing cost and the
decrement, or because the reduced exposure the underlying has to the underlying futures index at a time of a decline may nevertheless
reflect significantly greater than 100% participation in the decline of the underlying futures index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Certain features of the underlying &ndash; including the fact that it
references the underlying futures index, and not the Nasdaq-100 Index directly, and the decrement of 6% per annum &ndash; are designed
to reduce the cost to us and our affiliates of hedging transactions that we intend to enter into in connection with the securities as
compared to an otherwise comparable index without these features.&nbsp;&nbsp;These features will reduce the performance of the underlying
as compared to an otherwise comparable index without these features.&nbsp;&nbsp;The reduced cost of hedging may make it possible for certain
terms of the securities to be more favorable to you than would otherwise be the case.&nbsp;&nbsp;However, there can be no assurance that
these more favorable terms will offset the negative effects of these features on the performance of the underlying, and your return on
the securities may ultimately be less favorable than it would have been without these more favorable terms but with an index that does
not contain these features.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This section contains only a summary description of the underlying and
does not describe all of its important features in detail.&nbsp;&nbsp;Before investing in the securities, you should carefully review
the more detailed description of the underlying in the accompanying index supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Examples</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples in the first section below illustrate how to determine
whether a contingent coupon will be paid following various valuation dates and whether the securities will be automatically called for
redemption during the autocall period. The examples in the second section below illustrate how to determine the payment at maturity on
the securities, assuming the securities are not automatically redeemed prior to maturity. The examples are solely for illustrative purposes,
do not show all possible outcomes and are not a prediction of any payment that may be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The examples below are based on the following hypothetical values and
do not reflect the actual initial underlying value, coupon barrier value or final barrier value. For the actual initial underlying value,
coupon barrier value and final barrier value, see the cover page of this pricing supplement. We have used these hypothetical values, rather
than the actual values, to simplify the calculations and aid understanding of how the securities work. However, you should understand
that the actual payments on the securities will be calculated based on the actual initial underlying value, coupon barrier value and final
barrier value, and not the hypothetical values indicated below. For ease of analysis, figures below have been rounded.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="width: 30%; border: #59AE43 1pt solid"><FONT STYLE="color: #59AE43"><B>Hypothetical initial underlying value:</B></FONT></TD>
    <TD STYLE="width: 70%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">100.00</TD></TR>
  <TR>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid"><FONT STYLE="color: #59AE43"><B>Hypothetical coupon barrier value:</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">70.00 (70.00% of the hypothetical initial underlying value)</TD></TR>
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid"><FONT STYLE="color: #59AE43"><B>Hypothetical final barrier value:</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">60.00 (60.00% of the hypothetical initial underlying value)</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of Contingent Coupon Payments
and any Payment upon Automatic Early Redemption </I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 1 &mdash; The securities are automatically redeemed on the
first trading day during the autocall period, which is also a valuation date.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Date</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical closing value of the underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical payment per $1,000 security on related contingent coupon payment date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">First valuation date</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">85<BR>
(greater than coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$14.167</B><BR>
(contingent coupon is paid; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Second valuation date</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">45<BR>
(less than coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupon; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Third valuation date</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">110<BR>
(greater than coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$14.167</B><BR>
(contingent coupon is paid; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Fourth valuation date</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">95</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(greater than coupon barrier value)</P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$14.167</B><BR>
(contingent coupon is paid; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Fifth through eleventh valuation dates</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Various</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(all less than coupon barrier value)</P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupons; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Twelfth valuation date (first trading day during the autocall period)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">110<BR>
(greater than coupon barrier value and initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,014.167</B><BR>
(contingent coupon is paid; securities redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Total payment:</B></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,056.668</B></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the closing value of the underlying on the first trading day
during the autocall period, which is also the twelfth valuation date, is greater than or equal to the initial underlying value, the securities
would be automatically redeemed and you would receive $1,014.167 per security (or $1,000 <I>plus</I> the applicable contingent coupon
payment). When added to the contingent coupon payments received with respect to the prior valuation dates, the total amount you would
receive for each security is $1,056.668. No further payments will be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Example 2 &mdash; The securities are automatically redeemed on the
fifteenth trading day during the autocall period (which is not a valuation date).</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Date</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical closing value of the underlying</B></FONT></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Hypothetical payment per $1,000 security on related contingent coupon payment date</B></FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">First valuation date</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">90<BR>
(greater than coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$14.167</B><BR>
(contingent coupon is paid; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Second through eleventh valuation dates</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid">
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">Various</P>
    <P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">(all less than coupon barrier value)</P></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupons; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Twelfth valuation date (first trading day during the autocall period)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">50<BR>
(less than coupon barrier value and initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$0.00</B><BR>
(no contingent coupon; securities not redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">Fifteenth trading day during the autocall period (which is not a valuation date)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">110<BR>
(greater than initial underlying value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,000.00</B><BR>
(no contingent coupon; securities redeemed)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Total payment:</B></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,014.167</B></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Because the closing value of the underlying on the fifteenth trading
day during the autocall period is greater than or equal to the initial underlying value, the securities would be automatically redeemed
and you would receive the $1,000 stated principal amount per security. You would not</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">receive any contingent coupon payment on the automatic early redemption
date. When added to the contingent coupon payment received with respect to the prior valuation dates, the total amount you would receive
for each security is $1,014.167. No further payments will be made on the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"><B><I>Hypothetical Examples of the Payment at Maturity
on the Securities</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The next four hypothetical examples illustrate the calculation of the
payment at maturity on the securities, assuming that the securities have not been earlier automatically redeemed and that the final underlying
value is as indicated below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 34%; border: #59AE43 1pt solid; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical final underlying value</B></TD>
    <TD STYLE="width: 33%; border-top: #59AE43 1pt solid; border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>Hypothetical payment at maturity per $1,000 security</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 3</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">110<BR>
(greater than coupon barrier value and final barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,014.167</B><BR>
(contingent coupon is paid)</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 4</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">65<BR>
(greater than final barrier value; less than coupon barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$1,000.00</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 5</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">30<BR>
(less than final barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$300.00</B></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Example 6</B></FONT></TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center">20<BR>
(less than final barrier value)</TD>
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; text-align: center"><B>$200.00</B></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 3:</B></FONT> The final underlying
value is greater than the final barrier value. Accordingly, at maturity, you would receive the stated principal amount of the securities
<I>plus</I> the contingent coupon payment due at maturity, but you would not participate in the appreciation of the underlying.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 4:</B></FONT> The final underlying
value is less than the coupon barrier value but greater than the final barrier value. Accordingly, at maturity, you would receive the
stated principal amount of the securities, but would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 5:</B></FONT> The final underlying
value is less than the final barrier value. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000 + ($1,000 &times; the underlying return)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; -70.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + -$700.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $300.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value is less than the
final barrier value, you would lose a significant portion of your investment in the securities. In addition, because the final underlying
value is below the coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="color: #59AE43"><B>Example 6:</B></FONT> The final underlying
value is less than the final barrier value. Accordingly, at maturity, you would receive a payment per security calculated as follows:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Payment at maturity = $1,000 + ($1,000 &times; the underlying return)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + ($1,000 &times; -80.00%)</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $1,000 + -$800.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">= $200.00</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In this scenario, because the final underlying value is less than the
final barrier value, you would lose a significant portion of your investment in the securities. In addition, because the final underlying
value is below the coupon barrier value, you would not receive any contingent coupon payment at maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is possible that the closing value of the underlying will be less
than the coupon barrier value on each valuation date and less than the final barrier value on the final valuation date, such that you
will not receive any contingent coupon payments over the term of the securities and will receive significantly less than the stated principal
amount of your securities, and possibly nothing, at maturity.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Summary Risk Factors</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">An investment in the securities is significantly riskier than an investment
in conventional debt securities. The securities are subject to all of the risks associated with an investment in our conventional debt
securities (guaranteed by Citigroup Inc.), including the risk that we and Citigroup Inc. may default on our obligations under the securities,
and are also subject to risks associated with the underlying. Accordingly, the securities are suitable only for investors who are capable
of understanding the complexities and risks of the securities. You should consult your own financial, tax and legal advisors as to the
risks of an investment in the securities and the suitability of the securities in light of your particular circumstances.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following is a summary of certain key risk factors for investors
in the securities. You should read this summary together with the more detailed description of risks relating to an investment in the
securities contained in the section &ldquo;Risk Factors Relating to the Securities&rdquo; beginning on page EA-7 in the accompanying product
supplement and &ldquo;Risk Factors Relating to the Indices&rdquo; beginning on page IS-4 in the accompanying index supplement. You should
also carefully read the risk factors included in the accompanying prospectus supplement and in the documents incorporated by reference
in the accompanying prospectus, including Citigroup Inc.&rsquo;s most recent Annual Report on Form 10-K and any subsequent Quarterly Reports
on Form 10-Q, which describe risks relating to the business of Citigroup Inc. more generally.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Risks Relating to the Securities</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may lose a significant portion or all of your investment.</B> Unlike conventional debt securities, the securities do not provide
for the repayment of the stated principal amount at maturity in all circumstances. If the securities are not automatically redeemed prior
to maturity, your payment at maturity will depend on the final underlying value. If the final underlying value is less than the final
barrier value, you will lose 1% of the stated principal amount of your securities for every 1% by which the underlying has declined from
the initial underlying value. There is no minimum payment at maturity on the securities, and you may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You will not receive any contingent coupon on the contingent coupon payment date following any valuation date on which the closing
value of the underlying is less than the coupon barrier value.</B> A contingent coupon payment will be made on a contingent coupon payment
date if and only if the closing value of the underlying on the immediately preceding valuation date is greater than or equal to the coupon
barrier value. If the closing value of the underlying on any valuation date is less than the coupon barrier value, you will not receive
any contingent coupon payment on the immediately following contingent coupon payment date. If the closing value of the underlying on each
valuation date is below the coupon barrier value, you will not receive any contingent coupon payments over the term of the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Higher contingent coupon rates are associated with greater risk.</B> The securities offer contingent coupon payments at an annualized
rate that, if all are paid, would produce a yield that is generally higher than the yield on our conventional debt securities of the same
maturity. This higher potential yield is associated with greater levels of expected risk as of the pricing date for the securities, including
the risk that you may not receive a contingent coupon payment on one or more, or any, contingent coupon payment dates and the risk that
the value of what you receive at maturity may be significantly less than the stated principal amount of your securities and may be zero.
The volatility of the closing value of the underlying is an important factor affecting these risks. Greater expected volatility of the
closing value of the underlying as of the pricing date may result in a higher contingent coupon rate, but would also represent a greater
expected likelihood as of the pricing date that the closing value of the underlying on one or more valuation dates will be less than the
coupon barrier value, such that you will not receive one or more, or any, contingent coupon payments during the term of the securities
and that the final underlying value will be less than the final barrier value, such that you will not be repaid the stated principal amount
of your securities at maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>You may not be adequately compensated for assuming the downside risk of the underlying.</B> The potential contingent coupon payments
on the securities are the compensation you receive for assuming the downside risk of the underlying, as well as all the other risks of
the securities. That compensation is effectively &ldquo;at risk&rdquo; and may, therefore, be less than you currently anticipate. First,
the actual yield you realize on the securities could be lower than you anticipate because the coupon is &ldquo;contingent&rdquo; and you
may not receive a contingent coupon payment on one or more, or any, of the contingent coupon payment dates. Second, the contingent coupon
payments are the compensation you receive not only for the downside risk of the underlying, but also for all of the other risks of the
securities, including the risk that the securities may be automatically redeemed prior to maturity, interest rate risk and our and Citigroup
Inc.&rsquo;s credit risk. If those other risks increase or are otherwise greater than you currently anticipate, the contingent coupon
payments may turn out to be inadequate to compensate you for all the risks of the securities, including the downside risk of the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities may be automatically redeemed prior to maturity, limiting your opportunity to receive contingent coupon payments.</B>
On any trading day during the autocall period, the securities will be automatically called for redemption if the closing value of the
underlying on that trading day is greater than or equal to the initial underlying value. As a result, if the underlying performs in a
way that would otherwise be favorable, the securities are likely to be automatically redeemed, cutting short your opportunity to receive
contingent coupon payments. If the securities are automatically redeemed prior to maturity, you may not be able to reinvest your funds
in another investment that provides a similar yield with a similar level of risk.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If the securities are automatically redeemed on a trading day during the autocall period that is not a valuation date, you will
not receive any contingent coupon payment on the automatic early redemption date.</B> If the closing value of the underlying is greater
than or equal to the initial underlying value on a trading day during the autocall period that is not a valuation date, the securities
will be automatically redeemed and you will not receive any contingent coupon payment in respect of the period from and including the
immediately preceding contingent coupon payment date to but excluding the automatic early redemption date. In addition, you will not be
entitled to receive any further contingent coupon payments after the securities have been automatically redeemed.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities offer downside exposure to the underlying, but no upside exposure to the underlying.</B> You will not participate
in any appreciation in the value of the underlying over the term of the securities. Consequently, your return on the securities will be
limited to the contingent coupon payments you receive, if any, and may be significantly less than the return on the underlying over the
term of the securities. In addition, as an investor in the securities, you will not receive any dividends or other distributions or have
any other rights with respect to the underlying.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The performance of the securities will depend on the closing value of the underlying solely on the valuation dates and the trading
days during the autocall period, which makes the securities particularly sensitive to volatility in the closing value of the underlying
on or near the valuation dates and the trading days during the autocall period.</B> Whether the contingent coupon will be paid on any
given contingent coupon payment date and whether the securities will be automatically redeemed prior to maturity will depend on the closing
value of the underlying solely on the applicable valuation dates and the trading days during the autocall period, regardless of the closing
value of the underlying on other days during the term of the securities. If the securities are not automatically redeemed prior to maturity,
what you receive at maturity will depend solely on the closing value of the underlying on the final valuation date, and not on any other
day during the term of the securities. Because the performance of the securities depends on the closing value of the underlying on a limited
number of dates, the securities will be particularly sensitive to volatility in the closing value of the underlying on or near the valuation
dates and the trading days during the autocall period. You should understand that the closing value of the underlying has historically
been highly volatile.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are subject to the credit risk of Citigroup Global Markets Holdings Inc. and Citigroup Inc.</B> If we default on
our obligations under the securities and Citigroup Inc. defaults on its guarantee obligations, you may not receive anything owed to you
under the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities are&nbsp;riskier than securities with a shorter term.&nbsp;</B>The securities are relatively long-dated. Because
the securities are relatively long-dated, many of the risks of the securities are heightened as compared to securities with a shorter
term, because you will be subject to those risks for a longer period of time. In addition, the value of a longer-dated security is typically
less than the value of an otherwise comparable security with a shorter term.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.</B> The securities
will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the securities. CGMI currently
intends to make a secondary market in relation to the securities and to provide an indicative bid price for the securities on a daily
basis. Any indicative bid price for the securities provided by CGMI will be determined in CGMI&rsquo;s sole discretion, taking into account
prevailing market conditions and other relevant factors, and will not be a representation by CGMI that the securities can be sold at that
price, or at all. CGMI may suspend or terminate making a market and providing indicative bid prices without notice, at any time and for
any reason. If CGMI suspends or terminates making a market, there may be no secondary market at all for the securities because it is likely
that CGMI will be the only broker-dealer that is willing to buy your securities prior to maturity. Accordingly, an investor must be prepared
to hold the securities until maturity.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities on the pricing date, based on CGMI&rsquo;s proprietary pricing models and our internal funding
rate, is less than the issue price.</B> The difference is attributable to certain costs associated with selling, structuring and hedging
the securities that are included in the issue price. These costs include (i) any selling concessions or other fees paid in connection
with the offering of the securities, (ii) hedging and other costs incurred by us and our affiliates in connection with the offering of
the securities and (iii) the expected profit (which may be more or less than actual profit) to CGMI or other of our affiliates in connection
with hedging our obligations under the securities. These costs adversely affect the economic terms of the securities because, if they
were lower, the economic terms of the securities would be more favorable to you. The economic terms of the securities are also likely
to be adversely affected by the use of our internal funding rate, rather than our secondary market rate, to price the securities. See
&ldquo;The estimated value of the securities would be lower if it were calculated based on our secondary market rate&rdquo; below.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities was determined for us by our affiliate using proprietary pricing models.</B> CGMI derived
the estimated value disclosed on the cover page of this pricing supplement from its proprietary pricing models. In doing so, it may have
made discretionary judgments about the inputs to its models, such as the volatility of the closing value of the underlying, the dividend
yield on the underlying and interest rates. CGMI&rsquo;s views on these inputs may differ from your or others&rsquo; views, and as an
underwriter in this offering, CGMI&rsquo;s interests may conflict with yours. Both the models and the inputs to the models may prove to
be wrong and therefore not an accurate reflection of the value of the securities. Moreover, the estimated value of the securities set
forth on the cover page of this pricing supplement may differ from the value that we or our affiliates may determine for the securities
for other purposes, including for accounting purposes. You should not invest in the securities because of the estimated value of the securities.
Instead, you should be willing to hold the securities to maturity irrespective of the initial estimated value.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities would be lower if it were calculated based on our secondary market rate.</B> The estimated
value of the securities included in this pricing supplement is calculated based on our internal funding rate, which is the rate at which
we are willing to borrow funds through the issuance of the securities. Our internal funding rate is generally lower than our secondary
market rate, which is the rate that CGMI will use in determining the value of the securities for purposes of any purchases of the securities
from you in the secondary market. If the estimated value included in this pricing supplement were based on our secondary market rate,
rather than our internal funding rate, it would likely be lower. We determine our internal funding rate based on factors such as the costs
associated with the securities, which are generally higher than the costs associated with conventional debt securities, and our liquidity
needs and preferences. Our internal funding rate is not an interest rate that is payable on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">Because there is not an active market for traded instruments
referencing our outstanding debt obligations, CGMI determines our secondary market rate based on the market price of traded instruments
referencing the debt obligations of Citigroup Inc., our parent company and the guarantor of all payments due on the securities, but subject
to adjustments that CGMI makes in its sole discretion. As a result, our secondary market rate is not a market-determined measure of our
creditworthiness, but rather reflects the market&rsquo;s perception of our parent company&rsquo;s creditworthiness as adjusted for discretionary
factors such as CGMI&rsquo;s preferences with respect to purchasing the securities prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The estimated value of the securities is not an indication of the price, if any, at which CGMI or any other person may be willing
to buy the securities from you in the secondary market.</B> Any such secondary market price will fluctuate over the term of the securities
based on the market and other factors described in the next risk factor. Moreover, unlike the estimated value included in this pricing
supplement, any value of the securities determined for purposes of a secondary market transaction will be based on our secondary market
rate, which will likely result in a lower value for the securities than if our internal funding rate were used. In addition, any secondary
market price for the securities will be reduced by a bid-ask spread, which may vary depending on the aggregate stated principal amount
of the securities to be purchased in</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">the secondary market transaction, and the
expected cost of unwinding related hedging transactions. As a result, it is likely that any secondary market price for the securities
will be less than the issue price.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The value of the securities prior to maturity will fluctuate based on many unpredictable factors.</B> The value of your securities
prior to maturity will fluctuate based on the closing value of the underlying, the volatility of the closing value of the underlying,
the dividend yield on the underlying, interest rates generally, the time remaining to maturity and our and Citigroup Inc.&rsquo;s creditworthiness,
as reflected in our secondary market rate, among other factors described under &ldquo;Risk Factors Relating to the Securities&mdash;Risk
Factors Relating to All Securities&mdash;The value of your securities prior to maturity will fluctuate based on many unpredictable factors&rdquo;
in the accompanying product supplement. Changes in the closing value of the underlying may not result in a comparable change in the value
of your securities. You should understand that the value of your securities at any time prior to maturity may be significantly less than
the issue price.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Immediately following issuance, any secondary market bid price provided by CGMI, and the value that will be indicated on any brokerage
account statements prepared by CGMI or its affiliates, will reflect a temporary upward adjustment.</B> The amount of this temporary upward
adjustment will steadily decline to zero over the temporary adjustment period. See &ldquo;Valuation of the Securities&rdquo; in this pricing
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>If a material modification event occurs during the term of the securities, we may redeem the securities early for an amount that
may result in a significant loss on your investment.</B> See &ldquo;Additional Terms of the Securities&mdash;Material modification of
the Cboe Implied Volatility Indices&rdquo; in this pricing supplement for information about the events that may constitute a material
modification event.&nbsp;&nbsp;If a material modification event occurs, we may redeem the securities prior to the maturity date for an
amount equal to the early redemption amount determined as of the early redemption notice date.&nbsp;&nbsp;The early redemption amount
will be determined in a manner based upon (but not necessarily identical to) CGMI&rsquo;s then contemporaneous practices for determining
secondary market bid prices for the securities and similar instruments, subject to the exceptions and more detailed provisions set forth
under &ldquo;Additional Terms of the Securities&mdash;Material modification of the Cboe Implied Volatility Indices&rdquo; below.&nbsp;&nbsp;As
discussed above, any secondary market bid price is likely to be less than the issue price and, absent favorable changes in market conditions
and other relevant factors, is also likely to be less than the estimated value of the securities set forth on the cover page of this pricing
supplement.&nbsp;&nbsp;Accordingly, if a material modification event occurs, there is a significant likelihood that the early redemption
amount you receive will result in a loss on your investment in the securities. The early redemption amount may be significantly less than
the amount you would have received had we not elected to redeem the securities and had you been able instead to hold them to maturity.&nbsp;&nbsp;You
may lose up to all of your investment.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent may make determinations in connection with a material modification event and the early redemption amount
that could adversely affect your return upon early redemption.</B> The calculation agent will be required to determine whether a material
modification event has occurred. If the calculation agent determines that a material modification event has occurred and as a result we
elect to redeem the securities upon the occurrence of a material modification event, you may incur a significant loss on your investment
in the securities. In addition, the calculation agent has broad discretion to determine the early redemption amount, including the ability
to make adjustments to proprietary pricing models and inputs to those models in good faith and in a commercially reasonable manner.&nbsp;&nbsp;The
fact that the calculation agent is our affiliate may cause it to have interests that are adverse to yours as a holder of the securities.
Under the terms of the securities, the calculation agent has the authority to make determinations that may protect our economic interests
while resulting in a significant loss to you on your investment in the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>Our offering of the securities is not a recommendation of the underlying.</B> The fact that we are offering the securities does
not mean that we believe that investing in an instrument linked to the underlying is likely to achieve favorable returns. In fact, as
we are part of a global financial institution, our affiliates may have positions (including short positions) in the underlying or in instruments
related to the underlying, and may publish research or express opinions, that in each case are inconsistent with an investment linked
to the underlying. These and other activities of our affiliates may affect the closing value of the underlying in a way that negatively
affects the value of and your return on the securities.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The closing value of the underlying may be adversely affected by our or our affiliates&rsquo; hedging and other trading activities.</B>
We have hedged our obligations under the securities through CGMI or other of our affiliates, who have taken positions in the underlying
or in financial instruments related to the underlying and may adjust such positions during the term of the securities. Our affiliates
also take positions in the underlying or in financial instruments related to the underlying on a regular basis (taking long or short positions
or both), for their accounts, for other accounts under their management or to facilitate transactions on behalf of customers. These activities
could affect the closing value of the underlying in a way that negatively affects the value of and your return on the securities. They
could also result in substantial returns for us or our affiliates while the value of the securities declines.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>We and our affiliates may have economic interests that are adverse to yours as a result of our affiliates&rsquo; business activities.</B>
Our affiliates engage in business activities with a wide range of companies. These activities include extending loans, making and facilitating
investments, underwriting securities offerings and providing advisory services. These activities could involve or affect the underlying
in a way that negatively affects the value of and your return on the securities. They could also result in substantial returns for us
or our affiliates while the value of the securities declines. In addition, in the course of this business, we or our affiliates may acquire
non-public information, which will not be disclosed to you.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The calculation agent, which is an affiliate of ours, will make important determinations with respect to the securities.</B> If
certain events occur during the term of the securities, such as market disruption events and other events with respect to the underlying,
CGMI, as calculation agent, will be required to make discretionary judgments that could significantly affect your return on the securities.
In making these judgments, the calculation agent&rsquo;s interests as an affiliate of ours could be adverse to your interests as a holder
of the securities. See &ldquo;Risk Factors Relating to the Securities&mdash;Risk Factors Relating to All Securities&mdash;The calculation
agent, which is an affiliate of ours, will make important determinations with respect to the securities&rdquo; in the accompanying product
supplement.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><B>The U.S. federal tax consequences of an investment in the securities are unclear.</B> There is no direct legal authority regarding
the proper U.S. federal tax treatment of the securities, and we do not plan to request a ruling from the Internal Revenue Service (the
&ldquo;IRS&rdquo;).&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Consequently, significant aspects of the
tax treatment of the securities are uncertain, and the IRS or a court might not agree with the treatment of the securities as described
in &ldquo;United States Federal Tax Considerations&rdquo; below.&nbsp;&nbsp;If the IRS were successful in asserting an alternative treatment
of the securities, the tax consequences of the ownership and disposition of the securities might be materially and adversely affected.&nbsp;&nbsp;Moreover,
future legislation, Treasury regulations or IRS guidance could adversely affect the U.S. federal tax treatment of the securities, possibly
retroactively.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">Non-U.S. investors should note that persons
having withholding responsibility in respect of the securities may withhold on any coupon payment paid to a non-U.S. investor, generally
at a rate of 30%.&nbsp;&nbsp;To the extent that we have withholding responsibility in respect of the securities, we intend to so withhold.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">You should read carefully the discussion
under &ldquo;United States Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying
product supplement and &ldquo;United States Federal Tax Considerations&rdquo; in this pricing supplement.&nbsp;&nbsp;You should also consult
your tax adviser regarding the U.S. federal tax consequences of an investment in the securities, as well as tax consequences arising under
the laws of any state, local or non-U.S. taxing jurisdiction.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><B>Summary of Key Risks Relating
to the Underlying</B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white"><I>The following is a summary
of key risks relating to the underlying. The summary below should be read together with the more detailed risk factors relating to the
underlying described in &ldquo;Risk Factors Relating to the Indices&rdquo; in the accompanying index supplement. The following discussion
of risks should also be read together with the section &ldquo;Description of the Nasdaq-100 Futures Edge Volatility Indices&rdquo; in
the accompanying index supplement, which defines and further describes a number of the terms and concepts referred to below.</I></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying is highly risky because it may reflect highly leveraged exposure to the underlying
futures index and may therefore experience a decline that is many multiples of any decline in the underlying futures index.&nbsp;&nbsp;</B>The
underlying tracks exposure to the underlying futures index on a volatility targeted basis, less a decrement of 6% per annum.&nbsp;&nbsp;The
underlying has a volatility target, which it attempts to achieve by applying leverage to its exposure to the underlying futures index
(up to a maximum of 500%) when the implied volatility of the Nasdaq-100 Index<SUP>&reg;</SUP> is less than the volatility target, and
by reducing its exposure to the underlying futures index below 100% when the implied volatility of the Nasdaq-100 Index<SUP>&reg;</SUP>
is greater than the volatility target.&nbsp;&nbsp;It is expected that the implied volatility of the Nasdaq-100 Index<SUP>&reg;</SUP> will
frequently be less than the volatility target, and therefore it is expected that the underlying will frequently have leveraged (more than
100%) exposure to the underlying futures index.&nbsp;&nbsp;If the underlying futures index declines at a time when the underlying has
leveraged exposure to it, the decline in the underlying will be equal to the decline in the underlying futures index multiplied by the
leverage (subject to further reduction as a result of the decrement).&nbsp;&nbsp;For example, if the underlying futures index declines
by 5% at a time when the underlying has 500% leveraged exposure to the underlying futures index, the underlying will decline by 25% over
that time (subject to further reduction as a result of the decrement).&nbsp;&nbsp;This potential for losses on a highly leveraged basis
makes the underlying highly risky.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may realize significant losses if it is not consistently successful in increasing
exposure to the underlying futures index in advance of increases in the underlying futures index and reducing exposure to the underlying
futures index in advance of declines in the underlying futures index.&nbsp;&nbsp;</B>The underlying methodology is premised on the following
key assumptions: (1) that there will be an inverse relationship between performance and volatility, so that the underlying futures index
will tend to increase in times of lower volatility and decline in times of higher volatility; (2) that the implied volatility of the Nasdaq-100
Index<SUP>&reg;</SUP>, as derived from the market prices of exchange-traded options on the Nasdaq-100 Index<SUP>&reg;</SUP> on each weekly
rebalancing date, will be an effective predictor of future volatility of the underlying futures index over the next week; and (3) that
the underlying&rsquo;s volatility target will be an effective level of volatility at which to draw the line between leveraged exposure
and deleveraged exposure to the underlying futures index.&nbsp;&nbsp;There is no guarantee that these assumptions will be proven correct
over any given time period.&nbsp;&nbsp;If any of these assumptions does not prove to be consistently correct, then the underlying may
perform poorly as a result of having highly leveraged exposure to the underlying futures index at a time of declines and/or having reduced
exposure to the underlying futures index at a time of increases.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may be adversely affected by a time lag in its volatility targeting mechanism.&nbsp;&nbsp;</B>The
underlying resets the leveraged exposure of each sub-index to the underlying futures index on a weekly basis.&nbsp;&nbsp;If the implied
volatility of the Nasdaq-100 Index<SUP>&reg;</SUP> at the rebalancing time on the rebalancing date for a given sub-index is relatively
low, that sub-index will retain relatively high leveraged exposure to the underlying futures index for the next week even if the volatility
of the Nasdaq-100 Index<SUP>&reg;</SUP> spikes and the underlying futures index declines significantly in value immediately after the
rebalancing time on that rebalancing date.&nbsp;&nbsp;That sub-index may consequently have highly leveraged exposure to a week&rsquo;s
worth of declines in the value of the underlying futures index before it has a chance to reset its leverage.&nbsp;&nbsp;In the case of
a sudden increase in volatility and a sudden decline in value, multiple sub-indices may have highly leveraged exposure to declines over
multiple days, and the underlying may experience poor performance as a result.&nbsp;&nbsp;Conversely, if significant appreciation in the
underlying futures index follows closely on a period of high Nasdaq-100 Index<SUP>&reg;</SUP> volatility, the time lag may cause the underlying
to have low exposure to the underlying futures index when that appreciation occurs.&nbsp;&nbsp;Taken together, these factors may cause
the underlying to perform particularly poorly in a temporary market crash &ndash; a sudden significant decline that is quickly reversed.&nbsp;&nbsp;In
that scenario, the underlying would participate on a highly leveraged basis in the decline and then fail to participate fully in the recovery.&nbsp;&nbsp;
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may be adversely affected by a &ldquo;decay&rdquo; effect.&nbsp;&nbsp;</B>If
the underlying is not consistently successful in increasing exposure to the underlying futures index in advance of increases in the underlying
futures index and reducing exposure to the underlying futures index in advance of declines in the underlying futures index, then the underlying
is also expected to be subject to a &ldquo;decay&rdquo; effect, which will exacerbate the decline that results from having highly leveraged
exposure to declines in the underlying futures index.&nbsp;&nbsp;The decay effect would result from the fact that each sub-index of the
underlying resets its leveraged exposure to the underlying futures index on a weekly basis, and would manifest any time the underlying
futures index moves in one direction one week and another direction the next.&nbsp;&nbsp;The decay effect would result because resetting
leverage after an increase but in advance of a decline would cause the underlying to have increased exposure to that decline, and resetting
leverage following a decline but in advance of an increase would cause the underlying to have decreased exposure to </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">that increase.&nbsp;&nbsp;The
more this fact pattern repeats, the lower the performance of the underlying would be relative to the performance of the underlying futures
index.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying futures index is expected to underperform the Nasdaq-100 Index<SUP>&reg;</SUP>
because of an implicit financing cost.&nbsp;&nbsp;</B>The underlying futures index is a futures-based index.&nbsp;&nbsp;As a futures-based
index, it is expected to reflect not only the performance of its reference index (the Nasdaq-100 Index<SUP>&reg;</SUP>), but also the
implicit cost of a financed position in that reference index.&nbsp;&nbsp;The cost of this financed position will adversely affect the
value of the underlying futures index.&nbsp;&nbsp;Any increase in market interest rates will be expected to further increase this implicit
financing cost and will increase the negative effect on the performance of the underlying futures index.&nbsp;&nbsp;Because of this implicit
financing cost, the underlying futures index is expected to underperform the total return performance of the Nasdaq-100 Index<SUP>&reg;</SUP>.
Any leverage applied to the underlying futures index will also be applied to the implicit financing cost.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may realize significant losses because it may reflect leveraged exposure to
the implicit financing cost.&nbsp;&nbsp;</B>If the underlying has leveraged exposure to the underlying futures index, the implicit financing
cost will be amplified by the leverage. Even during a time when the Nasdaq-100 Index<SUP>&reg;</SUP> does not decline, the underlying
may realize significant losses if it has leveraged exposure to the underlying futures index because of a leveraged exposure to the implicit
financing cost.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The closing value of the underlying futures index is based on the fixing price of its reference
futures contract, rather than the settlement price.</B>&nbsp;&nbsp;The value of the underlying is determined by the closing value of the
underlying futures index, which is based on the fixing price of its reference futures contract rather than the settlement price of such
contract. Although the fixing price of the reference futures contract is expected to be similar to the settlement price of such contract,
they may vary. Therefore, the value of the underlying may be different, and may be less than, the value of the underlying if the closing
price were determined by reference to the settlement price of the reference futures contract.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The performance of the underlying will be reduced by a decrement of 6% per annum.</B>&nbsp;&nbsp;The
underlying is a decrement index, which means that the value of each sub-index of the underlying will be reduced at a rate of 6% per annum.&nbsp;&nbsp;The
decrement will be a significant drag on the performance of the underlying, potentially offsetting positive returns that would otherwise
result from the underlying methodology, exacerbating negative returns of the underlying methodology and causing the level of the underlying
to decline steadily if the return of the underlying methodology would otherwise be relatively flat.&nbsp;&nbsp;The underlying will not
appreciate unless the return of the underlying methodology is sufficient to offset the negative effects of the decrement, and then only
to the extent that the return of the underlying methodology is greater than the decrement.&nbsp;&nbsp;As a result of the decrement, the
level of the underlying may decline even if the return of the underlying methodology would otherwise have been positive.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may not fully participate in any appreciation of the underlying futures index.&nbsp;&nbsp;</B>At
any time when the implied volatility of the Nasdaq-100 Index<SUP>&reg;</SUP> is greater than the volatility target, the underlying will
have less than 100% exposure to the underlying futures index and therefore will not fully participate in any appreciation of the underlying
futures index.&nbsp;&nbsp;For example, if the underlying has 50% exposure to the underlying futures index at a time when the underlying
futures index appreciates by 5%, the underlying would appreciate by only 2.5% (before giving effect to the decrement).&nbsp;&nbsp;The
decrement is deducted daily at a rate of 6% per annum even when the underlying has less than 100% exposure to the underlying futures index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may perform less favorably than it would if its volatility targeting mechanism
were based on an alternative volatility measure, such as actual realized volatility, rather than implied volatility.&nbsp;&nbsp;</B>The
underlying attempts to achieve its volatility target by adjusting its exposure to the underlying futures index based on the implied volatility
of the Nasdaq-100 Index<SUP>&reg;</SUP>.&nbsp;&nbsp;Implied volatility represents market expectations of future volatility as derived
from the price of exchange-traded options on the Nasdaq-100 Index<SUP>&reg;</SUP>.&nbsp;&nbsp;Market expectations of future volatility
may not accurately forecast future volatility.&nbsp;&nbsp;Accordingly, relying on implied volatility may cause the underlying to be less
successful in maintaining its volatility target than it would have been if it had relied instead on an alternative measure of volatility,
such as actual realized volatility.&nbsp;&nbsp;As a result, the underlying may have lower participation in underlying futures index increases,
and greater participation in underlying futures index declines, resulting in less favorable overall underlying performance, than it would
have had if another measure of volatility had been used. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying may significantly underperform the Nasdaq-100 Index<SUP>&reg;</SUP>.&nbsp;&nbsp;</B>It
is important to understand that the underlying provides exposure to the Nasdaq-100 Index<SUP>&reg;</SUP> that: (1) may be leveraged up
to 500%, or alternatively may reflect less than 100% participation; (2) is reduced by an implicit financing cost; (3) may be subject to
a decay effect; and (4) is reduced by a decrement of 6% per annum.<B>&nbsp;&nbsp;</B></FONT>As a result of these features, the underlying
may significantly underperform the <FONT STYLE="background-color: white">Nasdaq-100 Index<SUP>&reg;</SUP></FONT>.&nbsp;&nbsp;The underlying
is likely to significantly underperform the <FONT STYLE="background-color: white">Nasdaq-100 Index<SUP>&reg;</SUP></FONT> if it <FONT STYLE="background-color: white">is
not consistently successful in increasing exposure to the underlying futures index in advance of increases in the underlying futures index
and reducing exposure to the underlying futures index in advance of declines in the underlying futures index.&nbsp;&nbsp;The underlying
may significantly underperform the Nasdaq-100 even if it is consistently successful in these respects because of the implicit financing
cost and the decrement, or because the reduced exposure the underlying has to the underlying futures index at a time of a decline may
nevertheless reflect significantly greater than 100% participation in the decline of the underlying futures index.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The underlying has limited actual performance information.&nbsp;&nbsp;</B>The underlying
launched on April 28, 2025.&nbsp;&nbsp;Accordingly, the underlying has limited actual performance data.&nbsp;&nbsp;Because the underlying
is of recent origin with limited performance history, an investment linked to the underlying may involve a greater risk than an investment
linked to one or more indices with an established record of performance.&nbsp;&nbsp;A longer history of actual performance may have provided
more reliable information on which to assess the validity of the underlying&rsquo;s methodology.&nbsp;&nbsp;However, any historical performance
of the underlying is not an indication of how the underlying will perform in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>Hypothetical back-tested underlying performance information is subject to significant limitations.&nbsp;&nbsp;</B>All
information regarding the performance of the underlying prior to April 28, 2025 is hypothetical and back-tested, as the underlying did
not exist prior to that time.&nbsp;&nbsp;It is </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">important to understand
that hypothetical back-tested underlying performance information is subject to significant limitations, in addition to the fact that past
performance is never a guarantee of future performance.&nbsp;&nbsp;In particular:</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">o</FONT></TD><TD><FONT STYLE="background-color: white">Citigroup Global Markets Limited developed the rules of the underlying with the benefit of hindsight&mdash;that
is, with the benefit of being able to evaluate how the underlying rules would have caused the underlying to perform had it existed during
the hypothetical back-tested period.&nbsp;&nbsp;The fact that the underlying generally appreciated over any portion of the hypothetical
back-tested period may not therefore be an accurate or reliable indication of any fundamental aspect of the underlying methodology.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">o</FONT></TD><TD><FONT STYLE="background-color: white">The hypothetical back-tested performance of the underlying might look different if it covered
a different historical period.&nbsp;&nbsp;The market conditions that existed during the historical period covered by the hypothetical
back-tested underlying performance information are not necessarily representative of the market conditions that will exist in the future.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif">o</FONT></TD><TD><FONT STYLE="background-color: white">NDXP options were not published for each weekday prior to August 8, 2022, and NDXP options were
not published at all prior to February 2, 2018.&nbsp;&nbsp;As a result, the calculation of the hypothetical back-tested values of the
underlying prior to August 8, 2022 differs from the calculation of the underlying today.&nbsp;&nbsp;</FONT>The hypothetical back-tested
performance of the underlying prior to <FONT STYLE="background-color: white">August 8, 2022 </FONT>may therefore differ from how the underlying
would have performed if NDXP options had been available with expirations on every weekday, as they are now.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">It is impossible to
predict whether the underlying will rise or fall. The actual future performance of the underlying may bear no relation to the historical
or hypothetical back-tested levels of the underlying.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>The index administrator and index calculation agent of the underlying, which is our affiliate,
may exercise judgments under certain circumstances in the calculation of the underlying</B>.&nbsp;&nbsp;Although the underlying is rules-based,
there are certain circumstances under which the index administrator or index calculation agent may be required to exercise judgment in
calculating the underlying.&nbsp;&nbsp;In exercising these judgments, the index administrator&rsquo;s status as our affiliate may cause
its interests to be adverse to yours.&nbsp;&nbsp;The index administrator and index calculation agent are not your fiduciaries and are
not obligated to take your interests into account in calculating the underlying.&nbsp;&nbsp;Any actions taken by the index administrator
or index calculation agent in calculating the level of the underlying could adversely affect the performance of the underlying. </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in"><FONT STYLE="background-color: white">Citigroup Global Markets
Limited may be required to make similar types of judgments in its capacity as index administrator and calculation agent for the underlying
futures index.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 0pt 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&sect;</FONT></TD><TD><FONT STYLE="background-color: white"><B>Changes that affect the Nasdaq-100 Index<SUP>&reg;</SUP>, futures contracts on the Nasdaq-100
Index<SUP>&reg;</SUP>, the Cboe Implied Volatility Indices or NDXP options may adversely affect the performance of the underlying.&nbsp;&nbsp;</B>The
sponsor of the Nasdaq-100 Index<SUP>&reg;</SUP> or the Cboe Implied Volatility Indices may at any time make methodological changes or
other changes in the manner in which one or more of those indices is calculated that could affect the value of the Nasdaq-100 Index<SUP>&reg;</SUP>
or the Cboe Implied Volatility Indices, as the case may be.&nbsp;&nbsp;The CME, on which the futures contracts tracked by the underlying
futures index trade, and the Nasdaq options exchanges, on which the NDXP options used to calculate the Cboe Implied Volatility Indices
trade, may at any time change the terms of those contracts or options or make other changes that could affect their value.&nbsp;&nbsp;We
are not affiliated with Nasdaq or Cboe and, accordingly, we have no control over any such changes they may make.&nbsp;&nbsp;Such changes
could adversely affect the performance of the underlying and the value of and your return on securities linked to the underlying.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Additional Terms of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Market disruption events.&nbsp;</B>For purposes of determining whether
a market disruption event occurs with respect to the underlying, each reference to the &ldquo;Underlying Index&rdquo; in the section &ldquo;Description
of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Index&mdash;Definitions of Market Disruption Event
and Scheduled Trading Day and Related Definitions&rdquo; in the accompanying product supplement shall be deemed replaced with a reference
to the &ldquo;Underlying Index, the Citi Equity US Tech Large Cap QX Market Tracker Series 4 Index or the Nasdaq-100 Index<SUP>&reg;</SUP>&rdquo;.&nbsp;&nbsp;References
in the section &ldquo;Description of the Securities&mdash;Certain Additional Terms for Securities Linked to an Underlying Index&mdash;Definitions
of Market Disruption Event and Scheduled Trading Day and Related Definitions&rdquo; in the accompanying product supplement to the securities
comprising an Underlying Index shall be deemed to include futures contracts comprising an Underlying Index.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Material modification of the Cboe Implied Volatility Indices.</B>
If the sponsor of the Cboe Implied Volatility Indices announces that it will make, or that it will undertake a consultation with respect
to, a material change in the formula for or the method of calculating the Cboe Implied Volatility Indices or any other material modification
of the Cboe Implied Volatility Indices (other than a modification prescribed in that formula or method to maintain the indices in the
event of changes in an index component and other routine events) (any such announcement, a &ldquo;<B>material modification event</B>&rdquo;),
then we will have the right, but not the obligation, to redeem the securities, in whole and not in part, by providing written notice of
our election to exercise that right to the trustee (the date of such notice, the &ldquo;<B>early redemption notice date</B>&rdquo;) on
a redemption date of our election that is no later than the 30th business day immediately following the early redemption notice date or
earlier than the fifth business day following the early redemption notice date. A material modification event need not be continuing on
the early redemption notice date or on the redemption date.&nbsp;&nbsp;The amount due and payable on the securities upon such redemption
will be equal to the early redemption amount determined as of the early redemption notice date. Any modification to the Cboe Implied Volatility
Indices will be treated as a material modification unless made under the following circumstances: (i) to exercise routine judgment in
the administration of the rules, provided that such routine judgment will not include deviations or alterations to the rules designed
to improve the financial performance of the underlying or any other index; (ii) to correct errors in implementation of the rules or calculations
made pursuant to the rules; or (iii) to make an adjustment to respond to an unanticipated event outside of the control of the sponsor
of the Cboe Implied Volatility Indices, such as a disruption in the financial markets for specific assets or in a particular jurisdiction,
regulatory compliance requirement, force majeure or any other unanticipated event of similar magnitude and significance.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The &ldquo;<B>early redemption amount</B>&rdquo; will be the fair value
of the securities determined by the calculation agent as of the early redemption notice date in good faith and in a manner based upon
(but not necessarily identical to) CGMI&rsquo;s then contemporaneous practices for determining a secondary market bid price for the securities
and similar instruments.&nbsp;&nbsp;In determining the early redemption amount, the calculation agent may take into account proprietary
pricing models and may make adjustments to those models or inputs to those models in good faith and in a commercially reasonable manner.&nbsp;&nbsp;The
calculation agent may also take into account other facts, whether or not unique to us or our affiliates, in determining the early redemption
amount so long as it is in good faith and commercially reasonable.&nbsp;&nbsp;The early redemption amount may result in a significant
loss on your securities.&nbsp;&nbsp;See &ldquo;Summary Risk Factors&mdash;If a material modification event occurs during the term of the
securities, we may redeem the securities early for an amount that may result in a significant loss on your investment&rdquo; in this pricing
supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Hypothetical Back-Tested and Historical Performance
Information About the Underlying</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Hypothetical Back-tested and Historical Performance Information</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">This section contains hypothetical back-tested performance information
for the underlying calculated by Citigroup Global Markets Limited.&nbsp;&nbsp;All underlying performance information prior to April 28,
2025 is hypothetical and back-tested, as the underlying did not exist prior to that date.&nbsp;&nbsp;Hypothetical back-tested performance
information is subject to significant limitations.&nbsp;&nbsp;The sponsor of the underlying developed the rules of the underlying with
the benefit of hindsight&mdash;that is, with the benefit of being able to evaluate how the rules would have caused the underlying to perform
had it existed during the hypothetical back-tested period.&nbsp;&nbsp;The fact that the underlying appreciated at any time during the
hypothetical back-tested period may not therefore be an accurate or reliable indication of any fundamental aspect of the index methodology.&nbsp;&nbsp;Furthermore,
the hypothetical back-tested performance of the underlying might look different if it covered a different historical period.&nbsp;&nbsp;The
market conditions that existed during the hypothetical back-tested period may not be representative of market conditions that will exist
in the future.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The hypothetical back-tested performance information has been calculated
by Citigroup Global Markets Limited, in its capacity as index administrator, by applying the methodology substantially as described in
the accompanying index supplement to the actual and hypothetical back-tested values of the underlying futures index and utilizing the
actual and hypothetical back-tested values of the Cboe Implied Volatility Indices during the back-tested period.&nbsp;&nbsp;The underlying
futures index was first published on January 24, 2025, and the Cboe Implied Volatility Indices were first published on March 24, 2025.&nbsp;&nbsp;All
values of the underlying futures index and the Cboe Implied Volatility Indices prior to the dates of their initial publication and utilized
in the calculation of the hypothetical back-tested performance of the underlying are themselves hypothetical and back-tested.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Citigroup Global Markets Limited, as index administrator of the underlying
futures index, calculated the hypothetical back-tested values of the underlying futures index by applying the methodology substantially
as described in the accompanying index supplement to the actual published prices of the futures contracts tracked by the underlying futures
index during the period prior to its initial publication.&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Cboe, as publisher of the Cboe Implied Volatility Indices, calculated
the hypothetical back-tested values of the Cboe Implied Volatility Indices by applying the methodology substantially as described in the
accompanying index supplement to the actual published prices of NDXP options during the back-tested period, except that:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>NDXP options have been available for any weekday only since February 2, 2018.&nbsp;&nbsp;Prior to that time, hypothetical back-tested
values of the Cboe Implied Volatility Indices have been calculated by treating AM-settled NDX option contracts as PM-settled.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>NDXP options have traded on every weekday only since August 8, 2022.&nbsp;&nbsp;Prior to that time, the implied volatility for the
one-week period ending on a weekday for which no NDXP option was then traded was calculated by interpolating between the NDXP options
expiring immediately before and immediately after that weekday.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For these reasons, the hypothetical back-tested performance of the underlying
prior to August 8, 2022 may differ from how the underlying would have performed if NDXP options had been available with expirations on
every weekday, as they are now.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>It is impossible to predict whether the underlying will rise or fall.&nbsp;&nbsp;By
providing hypothetical back-tested and historical performance information in connection with the securities, we are not representing that
the underlying is likely to achieve gains or losses similar to those shown.&nbsp;&nbsp;In fact, there are frequently sharp differences
between hypothetical performance results and the actual results subsequently achieved by any particular investment.&nbsp;&nbsp;One of
the limitations of hypothetical performance information is that it did not involve financial risk and cannot account for all factors that
would affect actual performance. The actual future performance of the underlying may bear no relation to the hypothetical or historical
back-tested performance of the underlying.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Historical Information</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The closing value of the underlying on October 31, 2025 was 1,707.772.
The graph below shows the hypothetical back-tested closing values of the underlying for the period from January 2, 2015 to April 25, 2025,
and historical closing values of the underlying for the period April 28, 2025 to October 31, 2025.&nbsp;&nbsp;All data to the left of
the vertical red line in the graph below are hypothetical and back-tested.&nbsp;&nbsp;We obtained the closing values from Bloomberg L.P.,
without independent verification.&nbsp;&nbsp;<B>You should not take the hypothetical back-tested and historical values of the underlying
as an indication of future performance.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLSPACING="2" CELLPADDING="2" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #EAF3E0">
    <TD STYLE="width: 100%; border: #59AE43 1pt solid; text-align: center"><FONT STYLE="color: #59AE43"><B>Nasdaq-100 Futures 35% Edge Volatility 6% Decrement<FONT STYLE="font-family: Arial, Helvetica, Sans-Serif"><SUP>&trade;</SUP></FONT> Index ER &ndash; Hypothetical Back-Tested and Historical Closing Values</B></FONT><B><FONT STYLE="color: white"><BR>
</FONT><FONT STYLE="color: #59AE43">January 2, 2015 to October 31, 2025</FONT></B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-right: #59AE43 1pt solid; border-bottom: #59AE43 1pt solid; border-left: #59AE43 1pt solid; text-align: center"><IMG SRC="image_001.jpg" ALT="" STYLE="height: 315px; width: 577px"></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Comparison of Hypothetical Back-Tested and Historical Nasdaq-100
Futures 35% Edge Volatility 6% Decrement&trade; Index ER Performance Against Historical Nasdaq-100 Index<SUP>&reg;</SUP> Performance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graphs set forth a comparison of the hypothetical back-tested
and historical performance of the underlying against the historical performance of the Nasdaq-100 Index<SUP>&reg;</SUP>.&nbsp;&nbsp;The
first graph shows comparative performance data for the period from January 2, 2015 through October 31, 2025, each normalized to have a
closing value of 100.00 on January 2, 2015 to facilitate a comparison.&nbsp;&nbsp;The second graph shows comparative performance data
for the period from January 3, 2022 through October 31, 2025, each normalized to have a closing value of 100.00 on January 3, 2022 to
facilitate a comparison.&nbsp;&nbsp;The performance of the Nasdaq-100 Index<SUP>&reg;</SUP> shown below is its price return performance
&ndash; i.e., its performance without reflecting dividends. The total return performance of the Nasdaq-100 Index<SUP>&reg;</SUP> (i.e.,
its performance reflecting dividends) would be greater than the price return performance shown below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">All underlying performance information prior to April 28, 2025 is hypothetical
and back-tested, as the underlying did not exist prior to that date.&nbsp;&nbsp;Hypothetical back-tested performance information is subject
to the significant limitations described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>January 2, 2015 to October 31, 2025</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_002.jpg" ALT="" STYLE="height: 323px; width: 514px"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>January 3, 2022 to October 31, 2025</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><B><IMG SRC="image_003.jpg" ALT="" STYLE="height: 324px; width: 514px"></B></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B><I>PAST PERFORMANCE OF THE UNDERLYING AND RELATIVE
PERFORMANCE BETWEEN THE UNDERLYING AND THE NASDAQ-100 INDEX<SUP>&reg;</SUP> ARE NOT INDICATIVE OF FUTURE PERFORMANCE OR RELATIVE PERFORMANCE</I></B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Using the hypothetical back-tested and historical performance information
from the graphs above, the table below shows the annualized (annually compounded) performance of the underlying as compared to the Nasdaq-100
Index<SUP>&reg;</SUP> for the last year, the last three years and the last five years, each as of October 31, 2025.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD STYLE="width: 16%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 48%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Nasdaq-100 Futures 35% Edge Volatility 6% Decrement&trade; Index ER</B></FONT></TD>
    <TD STYLE="width: 36%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 1 Year</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">22.14%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">30.00%</FONT></TD></TR>
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 3 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">29.52%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">31.34%</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 5 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">14.07%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">18.51%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>
<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Comparison of Historical Underlying Futures Index Performance Against
Historical Nasdaq-100 Index<SUP>&reg;</SUP> Performance</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">The following graph sets forth a comparison of the hypothetical back-tested
and historical performance of the underlying futures index against the historical performance of the Nasdaq-100 Index<SUP>&reg;</SUP>
to illustrate the implicit financing cost reflected in the performance of the underlying futures index.&nbsp;&nbsp;The graph below shows
comparative performance data for the period from January 2, 2015 through October 31, 2025, each normalized to have a closing value of
100.00 on January 2, 2015 to facilitate a comparison.&nbsp;&nbsp;The performance of the Nasdaq-100 Index<SUP>&reg;</SUP> shown below is
its price return performance &ndash; i.e., its performance without reflecting dividends. The total return performance of the Nasdaq-100
Index<SUP>&reg;</SUP> (i.e., its performance reflecting dividends) would be greater than the price return performance shown below.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">All underlying futures index performance information prior to <FONT STYLE="background-color: white">January
24, 2025 </FONT>is hypothetical and back-tested as the underlying futures index did not exist prior to that time.&nbsp;&nbsp;Hypothetical
back-tested performance information is subject to the significant limitations described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><B>January 2, 2015 to October 31, 2025</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><IMG SRC="image_004.jpg" ALT="" STYLE="height: 321px; width: 510px"></FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center"><I>PAST PERFORMANCE OF THE UNDERLYING FUTURES
INDEX AND RELATIVE PERFORMANCE BETWEEN THE UNDERLYING FUTURES INDEX AND THE NASDAQ-100 INDEX<SUP>&reg;</SUP> ARE NOT INDICATIVE OF FUTURE
PERFORMANCE OR RELATIVE PERFORMANCE</I></P>

<P STYLE="font: bold 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Using the hypothetical back-tested and historical performance information
from the graph above, the table below shows the annualized (annually compounded) performance of the underlying futures index as compared
to the Nasdaq-100 Index<SUP>&reg;</SUP> for the last year, the last three years and the last five years, each as of October 31, 2025.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="2" CELLPADDING="2" ALIGN="CENTER" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 70%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #59AE43">
    <TD STYLE="width: 16%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 48%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Citi Equity US Tech Large Cap QX Market Tracker Series 4 Index</B></FONT></TD>
    <TD STYLE="width: 36%; text-align: center"><FONT STYLE="font-size: 10pt; color: white"><B>Nasdaq-100 Index<SUP>&reg;</SUP></B></FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 1 Year</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">24.34%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">30.00%</FONT></TD></TR>
  <TR STYLE="background-color: #EAF3E5">
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 3 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">25.35%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">31.34%</FONT></TD></TR>
  <TR>
    <TD STYLE="text-align: center"><FONT STYLE="font-size: 10pt; color: #59AE43"><B>Last 5 Years</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">15.16%</FONT></TD>
    <TD STYLE="vertical-align: bottom; text-align: center"><FONT STYLE="font-size: 10pt">18.51%</FONT></TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">United States Federal Tax Considerations</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">You should read carefully the discussion under &ldquo;United States
Federal Tax Considerations&rdquo; and &ldquo;Risk Factors Relating to the Securities&rdquo; in the accompanying product supplement and
&ldquo;Summary Risk Factors&rdquo; in this pricing supplement.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Due to the lack of any controlling legal authority, there is substantial
uncertainty regarding the U.S. federal tax consequences of an investment in the securities.&nbsp;&nbsp;In connection with any information
reporting requirements we may have in respect of the securities under applicable law, we intend (in the absence of an administrative determination
or judicial ruling to the contrary) to treat the securities for U.S. federal income tax purposes as prepaid forward contracts with associated
coupon payments that will be treated as gross income to you at the time received or accrued in accordance with your regular method of
tax accounting.&nbsp;&nbsp;In the opinion of our counsel, Davis Polk &amp; Wardwell LLP, which is based on current market conditions,
this treatment of the securities is reasonable under current law; however, our counsel has advised us that it is unable to conclude affirmatively
that this treatment is more likely than not to be upheld, and that alternative treatments are possible.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Assuming this treatment of the securities is respected and subject to
the discussion in &ldquo;United States Federal Tax Considerations&rdquo; in the accompanying product supplement, the following U.S. federal
income tax consequences should result under current law:</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Any coupon payments on the securities should be taxable as ordinary income to you at the time received or accrued in accordance with
your regular method of accounting for U.S. federal income tax purposes.</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Upon a sale or exchange of a security (including retirement at maturity), you should recognize capital gain or loss equal to the difference
between the amount realized and your tax basis in the security.&nbsp;&nbsp;For this purpose, the amount realized does not include any
coupon paid on retirement and may not include sale proceeds attributable to an accrued coupon, which may be treated as a coupon payment.&nbsp;&nbsp;Such
gain or loss should be long-term capital gain or loss if you held the security for more than one year.&nbsp;&nbsp;</TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Arial, Helvetica, Sans-Serif">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">We do not plan to request a ruling
from the IRS regarding the treatment of the securities. An alternative characterization of the securities could materially and adversely
affect the tax consequences of ownership and disposition of the securities, including the timing and character of income recognized. In
addition, the U.S. Treasury Department and the IRS have requested comments on various issues regarding the U.S. federal income tax treatment
of &ldquo;prepaid forward contracts&rdquo; and similar financial instruments and have indicated that such transactions may be the subject
of future regulations or other guidance. Furthermore, members of Congress have proposed legislative changes to the tax treatment of derivative
contracts. Any legislation, Treasury regulations or other guidance promulgated after consideration of these issues could materially and
adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect. You should consult your tax
adviser regarding possible alternative tax treatments of the securities and potential changes in applicable law. </FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>Withholding Tax on Non-U.S. Holders. </B>Because significant aspects
of the tax treatment of the securities are uncertain, persons having withholding responsibility in respect of the securities may withhold
on any coupon payment paid to Non-U.S. Holders (as defined in the accompanying product supplement), generally at a rate of 30%. To the
extent that we have (or an affiliate of ours has) withholding responsibility in respect of the securities, we intend to so withhold.&nbsp;&nbsp;In
order to claim an exemption from, or a reduction in, the 30% withholding, you may need to comply with certification requirements to establish
that you are not a U.S. person and are eligible for such an exemption or reduction under an applicable tax treaty. You should consult
your tax adviser regarding the tax treatment of the securities, including the possibility of obtaining a refund of any amounts withheld
and the certification requirement described above.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">As discussed under &ldquo;United
States Federal Tax Considerations&mdash;Tax Consequences to Non-U.S. Holders&rdquo; in the accompanying product supplement, Section 871(m)
of the Code and Treasury regulations promulgated thereunder (&ldquo;Section 871(m)&rdquo;) generally impose a 30% withholding tax on dividend
equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities (&ldquo;U.S.
Underlying Equities&rdquo;) or indices that include U.S. Underlying Equities.&nbsp;&nbsp;Section 871(m) generally applies to instruments
that substantially replicate the economic performance of one or more U.S. Underlying Equities, as determined based on tests set forth
in the applicable Treasury regulations.&nbsp;&nbsp;However, the regulations, as modified by an IRS notice, exempt financial instruments
issued prior to January 1, 2027 that do not have a &ldquo;delta&rdquo; of one.&nbsp;&nbsp;Based on the terms of the securities and representations
provided by us, our counsel is of the opinion that the securities should not be treated as transactions that have a &ldquo;delta&rdquo;
of one within the meaning of the regulations with respect to any U.S. Underlying Equity and, therefore, should not be subject to withholding
tax under Section 871(m).&nbsp;&nbsp;</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><FONT STYLE="background-color: white">A determination that the securities
are not subject to Section 871(m) is not binding on the IRS, and the IRS may disagree with this treatment.&nbsp;&nbsp;Moreover, Section
871(m) is complex and its application may depend on your particular circumstances, including your other transactions.&nbsp;&nbsp;You should
consult your tax adviser regarding the potential application of Section 871(m) to the securities.</FONT></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">We will not be required to pay any additional amounts with respect to
amounts withheld.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should read the section entitled &ldquo;United States Federal
Tax Considerations&rdquo; in the accompanying product supplement.&nbsp;&nbsp;The preceding discussion, when read in combination with that
section, constitutes the full opinion of Davis Polk &amp; Wardwell LLP regarding the material U.S. federal tax consequences of owning
and disposing of the securities.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0"><B>You should also consult your tax adviser regarding all aspects of
the U.S. federal income and estate tax consequences of an investment in the securities and any tax consequences arising under the laws
of any state, local or non-U.S. taxing jurisdiction.</B></P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Supplemental Plan of Distribution</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI, an affiliate of Citigroup Global Markets Holdings Inc. and the
underwriter of the sale of the securities, is acting as principal and will receive an underwriting fee of $20.00 for each security sold
in this offering. From this underwriting fee, CGMI will pay selected dealers not affiliated with CGMI a fixed selling concession of $20.00
for each security they sell. For the avoidance of doubt, any fees or selling concessions described in this pricing supplement will not
be rebated if the securities are automatically redeemed prior to maturity.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">See &ldquo;Plan of Distribution; Conflicts of Interest&rdquo; in the
accompanying product supplement and &ldquo;Plan of Distribution&rdquo; in each of the accompanying prospectus supplement and prospectus
for additional information.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Valuation of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">CGMI calculated the estimated value of the securities set forth on the
cover page of this pricing supplement based on proprietary pricing models. CGMI&rsquo;s proprietary pricing models generated an estimated
value for the securities by estimating the value of a hypothetical package of financial instruments that would replicate the payout on
the securities, which consists of a fixed-income bond (the &ldquo;bond component&rdquo;) and one or more derivative instruments underlying
the economic terms of the securities (the &ldquo;derivative component&rdquo;). CGMI calculated the estimated value of the bond component
using a discount rate based on our internal funding rate. CGMI calculated the estimated value of the derivative component based on a proprietary
derivative-pricing model, which generated a theoretical price for the instruments that constitute the derivative component based on various
inputs, including the factors described under &ldquo;Summary Risk Factors&mdash;The value of the securities prior to maturity will fluctuate
based on many unpredictable factors&rdquo; in this pricing supplement, but not including our or Citigroup Inc.&rsquo;s creditworthiness.
These inputs may be market-observable or may be based on assumptions made by CGMI in its discretionary judgment.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">For a period of approximately twelve months following issuance of the
securities, the price, if any, at which CGMI would be willing to buy the securities from investors, and the value that will be indicated
for the securities on any brokerage account statements prepared by CGMI or its affiliates (which value CGMI may also publish through one
or more financial information vendors), will reflect a temporary upward adjustment from the price or value that would otherwise be determined.
This temporary upward adjustment represents a portion of the hedging profit expected to be realized by CGMI or its affiliates over the
term of the securities. The amount of this temporary upward adjustment will decline to zero on a straight-line basis over the twelve-month
temporary adjustment period. However, CGMI is not obligated to buy the securities from investors at any time.&nbsp;&nbsp;See &ldquo;Summary
Risk Factors&mdash;The securities will not be listed on any securities exchange and you may not be able to sell them prior to maturity.&rdquo;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Validity of the Securities</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Davis Polk &amp; Wardwell LLP, as special products
counsel to Citigroup Global Markets Holdings Inc., when the securities offered by this pricing supplement have been executed and issued
by Citigroup Global Markets Holdings Inc. and authenticated by the trustee pursuant to the indenture, and delivered against payment therefor,
such securities and the related guarantee of Citigroup Inc. will be valid and binding obligations of Citigroup Global Markets Holdings
Inc. and Citigroup Inc., respectively, enforceable in accordance with their respective terms, subject to applicable bankruptcy, insolvency
and similar laws affecting creditors&rsquo; rights generally, concepts of reasonableness and equitable principles of general applicability
(including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses
no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed
above. This opinion is given as of the date of this pricing supplement and is limited to the laws of the State of New York, except that
such counsel expresses no opinion as to the application of state securities or Blue Sky laws to the securities.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In giving this opinion, Davis Polk &amp; Wardwell LLP has assumed the
legal conclusions expressed in the opinions set forth below of Alexia Breuvart, Secretary and General Counsel of Citigroup Global Markets
Holdings Inc., and Karen Wang, Senior Vice President &ndash; Corporate Securities Issuance Legal of Citigroup Inc.&nbsp;&nbsp;In addition,
this opinion is subject to the assumptions set forth in the letter of Davis Polk &amp; Wardwell LLP dated February 14, 2024, which has
been filed as an exhibit to a Current Report on Form 8-K filed by Citigroup Inc. on February 14, 2024, that the indenture has been duly
authorized, executed and delivered by, and is a valid, binding and enforceable agreement of, the trustee and that none of the terms of
the securities nor the issuance and delivery of the securities and the related guarantee, nor the compliance by Citigroup Global Markets
Holdings Inc. and Citigroup Inc. with the terms of the securities and the related guarantee respectively, will result in a violation of
any provision of any instrument or agreement then binding upon Citigroup Global Markets Holdings Inc. or Citigroup Inc., as applicable,
or any restriction imposed by any court or governmental body having jurisdiction over Citigroup Global Markets Holdings Inc. or Citigroup
Inc., as applicable.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Alexia Breuvart, Secretary and General Counsel of
Citigroup Global Markets Holdings Inc., (i) the terms of the securities offered by this pricing supplement have been duly established
under the indenture and the Board of Directors (or a duly authorized committee thereof) of Citigroup Global Markets Holdings Inc. has
duly authorized the issuance and sale of such securities and such authorization has not been modified or rescinded; (ii) Citigroup Global
Markets Holdings Inc. is validly existing and in good standing under the laws of the State of New York; (iii) the indenture has been duly
authorized, executed and delivered by Citigroup Global Markets Holdings Inc.; and (iv) the execution and delivery of such indenture and
of the securities offered by this pricing supplement by Citigroup Global Markets Holdings Inc., and the performance by Citigroup Global
Markets Holdings Inc. of its obligations thereunder, are within its corporate powers and do not contravene its certificate of incorporation
or bylaws or other constitutive documents. This opinion is given as of the date of this pricing supplement and is limited to the laws
of the State of New York.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Alexia Breuvart, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Global Markets Holdings Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed
above. In such examination, she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures
(other than those of officers of Citigroup Global Markets Holdings Inc.), the authenticity of all</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Arial, Helvetica, Sans-Serif; width: 100%; border-collapse: collapse"><TR STYLE="vertical-align: top"><TD STYLE="width: 100%; border-bottom: #59AE40 1pt solid; font-size: 22pt; color: #888888; text-align: right"><FONT STYLE="font-size: 14pt">Citigroup Global Markets Holdings Inc.</FONT></TD></TR><TR STYLE="vertical-align: top"><TD STYLE="font-size: 10pt">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">documents submitted to her or such persons as originals, the conformity
to original documents of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the
originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">In the opinion of Karen Wang, Senior Vice President &ndash; Corporate
Securities Issuance Legal of Citigroup Inc., (i) the Board of Directors (or a duly authorized committee thereof) of Citigroup Inc. has
duly authorized the guarantee of such securities by Citigroup Inc. and such authorization has not been modified or rescinded; (ii) Citigroup
Inc. is validly existing and in good standing under the laws of the State of Delaware; (iii) the indenture has been duly authorized, executed
and delivered by Citigroup Inc.; and (iv) the execution and delivery of such indenture, and the performance by Citigroup Inc. of its obligations
thereunder, are within its corporate powers and do not contravene its certificate of incorporation or bylaws or other constitutive documents.&nbsp;&nbsp;This
opinion is given as of the date of this pricing supplement and is limited to the General Corporation Law of the State of Delaware.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Karen Wang, or other internal attorneys with whom she has consulted,
has examined and is familiar with originals, or copies certified or otherwise identified to her satisfaction, of such corporate records
of Citigroup Inc., certificates or documents as she has deemed appropriate as a basis for the opinions expressed above. In such examination,
she or such persons has assumed the legal capacity of all natural persons, the genuineness of all signatures (other than those of officers
of Citigroup Inc.), the authenticity of all documents submitted to her or such persons as originals, the conformity to original documents
of all documents submitted to her or such persons as certified or photostatic copies and the authenticity of the originals of such copies.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">Contact</P>

<P STYLE="font: 14pt Arial, Helvetica, Sans-Serif; margin: 0pt 0; color: #59AE43">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">Clients may contact their local brokerage representative. Third-party
distributors may contact Citi Structured Investment Sales at (212) 723-7005.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&copy; 2025 Citigroup Global Markets Inc. All rights reserved. Citi
and Citi and Arc Design are trademarks and service marks of Citigroup Inc. or its affiliates and are used and registered throughout the
world.</P>

<P STYLE="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font: 9pt Arial, Helvetica, Sans-Serif; color: rgb(89,174,64); text-align: right; margin-top: 0pt; margin-bottom: 0pt">PS-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>dp236936_exfilingfees.htm
<DESCRIPTION>EX-FILING FEES
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Template (c) 2024 Novaworks, LLC -->
<!-- Field: Set; Name: AliasFileType; Value: Forms View; Template: Fee Exhibit\Fee Exhibit FC.xds -->
<!-- Field: Set; Name: Platform; Value: Novaworks Fee Exhibit Editor; Version: 1.0a -->
<!-- Field: Set; Name: Control; Value: VGVtcGxhdGU6IChkZWZhdWx0KQ0KQmFzZSBGb250OiBUaW1lcyBOZXcgUm9tYW4sIFRpbWVzLCBTZXJpZg0KQ2FwdGlvbiBTaXplOiAxMnB0DQpUYWJsZSBUaXRsZSBTaXplOiAxMXB0DQpUYWJsZSBIZWFkIFNpemU6IDhwdA0KVGFibGUgQm9keSBTaXplOiAxMHB0 -->
<!-- Field: Set; Name: MD5; Value: ef306dff5cd0f9a8e13ce7fb8967ac96 -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ffd="http://xbrl.sec.gov/ffd/2024">
<head>
  <title>Filing Fees</title>
  <meta http-equiv="Content-Type" content="text/html"/>
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">

<div style="display: none">
  <ix:header>
    <ix:hidden>
      <ix:nonNumeric name="ffd:SubmissnTp" contextRef="c_report" id="ixv-211">424B2</ix:nonNumeric>
      <ix:nonNumeric name="ffd:FeeExhibitTp" contextRef="c_report" id="ixv-212">EX-FILING FEES</ix:nonNumeric>
      <ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="c_report" id="ixv-213">0000831001</ix:nonNumeric>
      <ix:nonNumeric name="ffd:RegnFileNb" contextRef="c_report" id="ixv-214">333-270327</ix:nonNumeric>
      </ix:hidden>
    <ix:references>
      <link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd" xlink:type="simple"/>
      </ix:references>
    <ix:resources>
      <xbrli:context id="c_offering_1">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>1</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_offering_2">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          <xbrli:segment>
            <xbrldi:typedMember dimension="ffd:OfferingAxis"><dei:lineNo>2</dei:lineNo></xbrldi:typedMember>
            </xbrli:segment>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:context id="c_report">
        <xbrli:entity>
          <xbrli:identifier scheme="http://www.sec.gov/CIK">0000831001</xbrli:identifier>
          </xbrli:entity>
        <xbrli:period>
          <xbrli:startDate>2025-11-04</xbrli:startDate>
          <xbrli:endDate>2025-11-04</xbrli:endDate>
          </xbrli:period>
        </xbrli:context>
      <xbrli:unit id="USD">
        <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="pure">
        <xbrli:measure>xbrli:pure</xbrli:measure>
        </xbrli:unit>
      <xbrli:unit id="shares">
        <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unit>
      </ix:resources>
    </ix:header>
  </div>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: right; font-weight: bold">Ex-Filing Fees</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold">CALCULATION OF FILING FEE TABLES</p>

<p style="margin-top: 0pt; margin-bottom: 6pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="ffd:FormTp" contextRef="c_report" id="ixv-248">S-3</ix:nonNumeric></p>

<p style="margin-top: 0pt; margin-bottom: 0pt; font-size: 12pt; text-align: center; font-weight: bold">Citigroup Global Markets Holdings Inc.</p>

<p style="margin-top: 0pt; margin-bottom: 12pt; font-size: 12pt; text-align: center; font-weight: bold"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="c_report" id="ixv-249">Citigroup Inc</ix:nonNumeric>., as Guarantor</p>

<p style="border-top: Gray 3pt double; font-size: 11pt; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Table 1: Newly Registered and Carry Forward Securities</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; border-collapse: collapse; width: 100%">
<tr style="font-size: 2pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="width: 12%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 6.5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 9%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 0.5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td></tr>
<tr style="font-size: 8pt; vertical-align: bottom; text-align: center; font-weight: bold">
  <td style="border-bottom: Black 1pt solid">Line Item Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Type</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Security Class Title</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Notes</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Calculation<br/> Rule</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Amount Registered</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Proposed Maximum Offering<br/> Price Per Unit</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Maximum Aggregate Offering Price</td>
  <td style="padding-bottom: 1pt">&#160;</td>
  <td style="border-bottom: Black 1pt solid">Fee Rate</td>
  <td>&#160;</td>
  <td colspan="2" style="border-bottom: Black 1pt solid">Amount of Registration Fee</td></tr>
<tr style="font-size: 2pt; vertical-align: top; text-align: left">
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="22" style="padding-top: 2pt; font-style: italic; text-align: center; padding-bottom: 2pt">Newly Registered Securities</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_1" format="ixt:booleanfalse" id="ixv-250">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_1" id="ixv-251">Debt</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(1)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:Rule457rFlg" contextRef="c_offering_1" format="ixt:booleantrue" id="ixv-253">457(r)</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-254">1,777</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-255">1,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-256">1,777,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-257">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_1" id="ixv-258">245.40</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:PrevslyPdFlg" contextRef="c_offering_2" format="ixt:booleanfalse" id="ixv-259">Fees to be Paid</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="white-space: nowrap"><ix:nonNumeric name="ffd:OfferingSctyTp" contextRef="c_offering_2" id="ixv-260">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td><ix:nonNumeric name="ffd:OfferingSctyTitl" contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: center">(2)</td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonNumeric name="ffd:FeesOthrRuleFlg" contextRef="c_offering_2" format="ixt:booleantrue" id="ixv-262">Other</ix:nonNumeric></td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:AmtSctiesRegd" unitRef="shares" decimals="0" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-263">0</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxOfferingPricPerScty" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-264">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:MaxAggtOfferingPric" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-265">0.00</ix:nonFraction></td>
  <td>&#160;</td>
  <td style="text-align: center"><ix:nonFraction name="ffd:FeeRate" unitRef="pure" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-266">0.0001381</ix:nonFraction></td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:FeeAmt" unitRef="USD" decimals="INF" format="ixt:numdotdecimal" contextRef="c_offering_2" id="ixv-267">0.00</ix:nonFraction></td></tr>
<tr style="font-size: 4pt; vertical-align: top; text-align: left">
  <td style="width: 11%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 15%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="width: 5%">&#160;</td>
  <td style="width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 1%">&#160;</td>
  <td style="border-bottom: Black 1pt solid; width: 8%">&#160;</td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Offering Amounts:</td>
  <td>&#160;</td>
  <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlOfferingAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-268">1,777,000</ix:nonFraction></td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
 <td>$</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-269">245.40</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fees Previously Paid:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="text-align: right"><ix:nonFraction name="ffd:TtlPrevslyPdAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-270">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Total Fee Offsets:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 1pt solid">&#160;</td>
  <td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ffd:TtlOffsetAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-271">0.00</ix:nonFraction></td></tr>
<tr style="vertical-align: top; text-align: left">
  <td colspan="14" style="text-align: right">Net Fee Due:</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td>&#160;</td>
  <td style="border-bottom: Black 3pt double">$</td>
  <td style="border-bottom: Black 3pt double; text-align: right"><ix:nonFraction name="ffd:NetFeeAmt" contextRef="c_report" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" id="ixv-272">245.40</ix:nonFraction></td></tr>
</table>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; color: rgb(50,101,255); margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font-weight: bold; margin-top: 6pt; margin-bottom: 6pt">__________________________________________<br/>
Offering Note(s)</p>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(1)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ix:nonNumeric></td></tr>
  </table>

<table cellpadding="0" cellspacing="0" style="font-size: 10pt; margin-top: 0pt; margin-bottom: 6pt; width: 100%">
<tr style="vertical-align: top; text-align: justify">
  <td style="width: 15pt; text-align: right">(2)</td><td style="width: 5pt"/>
  <td style="text-align: justify"><ix:nonNumeric name="ffd:OfferingNote" escape="1" contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ix:nonNumeric></td></tr>
  </table>

<p style="border-top: Gray 3pt double; padding-top: 6pt; text-align: center; font-weight: bold; margin-top: 0pt; margin-bottom: 4pt">Narrative Disclosure</p>

<p style="margin-top: 6pt; margin-bottom: 6pt">
The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction name="ffd:NrrtvMaxAggtOfferingPric" decimals="INF" format="ixt:numdotdecimal" unitRef="USD" contextRef="c_report" id="ixv-275">1,777,000</ix:nonFraction>. <ix:nonNumeric name="ffd:FnlPrspctsFlg" contextRef="c_report" format="ixt:booleantrue" id="ixv-276">The
prospectus is a final prospectus for the related offering.</ix:nonNumeric></p>

<p style="margin-top: 6pt; margin-bottom: 6pt">&#160;</p>


</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $[ D$# 2(  A$! Q$!_\0
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M[0?]^3_\55"P%S_9MIAH<>1'_"?[H]ZL8N?[T'_?+?XT 3_:+[_GM!_WY/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MI-IFE23"$+(WR(?,S@GO7K2DHQ<GT/3E)13;,#Q!K\.K:28+>&12+@*0^,G
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M"5<$*1Z<8KUNO*?$]KIFMZ]/)>ZE/I-V2L,2:G!(L049#%&#!#GAASUSD$'
M /4X@!"@'3:.V*?38P%C4 @@ #([TZ@ J*Y_X])O]QOY5+45S_QZ3?[C?RH
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M\Z3_ )]I?S7_ !H\Z3_GVE_-?\: )J*A\Z3_ )]I?S7_ !H\Z3_GVE_-?\:
M)J*A\Z3_ )]I?S7_ !H\Z3_GVE_-?\: )J*A\Z3_ )]I?S7_ !H\Z3_GVE_-
M?\: )J*A\Z3_ )]I?S7_ !H\Z3_GVE_-?\: )J*A\Z3_ )]I?S7_ !H\Z3_G
MVE_-?\: )J*A\Z3_ )]I?S7_ !I1,^1_HTOYK_C0!+17+:!JKF;5I+B622&.
M7<&9P1&N3ZGI]*F\1ZQ)%H:RVA=/M#A5F5AC'4X(/M6'MX^SYS'VT>3G,7QE
MJ$%Y>P002;_LX8.1]W)QT-5QJ$4G@M['I,EPN,]P23D?D:E\/>'Y+N=+F]M)
M'LRFY<,!YA/OD5D-9R-J[6BQD2>>8]J\X^:O*FZE_:-?%H>;-SO[1KXM"2[-
MSIDU[8 -$DNT.AYR!R*]*T^W^R:;;6^2?+B49/7I7-7.FW%WXS$\EE(UJB*6
M\Q058!<8ZX/-=1YS_P#/M+^:_P"-=^%I.$I/Y([,/3<92?R1-14/G2?\^TOY
MK_C1YTG_ #[2_FO^-=IV$I4."AZ,,&O(Q"&GEC4\)OQ]%S_A7J_G2?\ /M+^
M:_XUSUSH4DWB..]2TS:NI$T;%!R5*\ 'Z5Q8NBZG+8Y,32=2UB[X5O)+S0HS
M*%S$QB7:,<*!C\:VJY+P=>E(+G3O)=GB<OE2.A..Y]JW]0OWLM.N+DP.#&A(
M+%<9[=_6M:$[T5)]%^1I1G^Z39>HK$\/:M<ZEIGG3Q&257*,T851VQQFM7SI
M/^?:7\U_QK:$E.*DNIK&2E%21-14/G2?\^TOYK_C1YTG_/M+^:_XU11!K$Z6
MVC7<LA8+Y17Y>N3P/U-<=X3TJ.]2\FE4[HX]D3'. 2""?>M?QC+*VD11A)(U
M><!LD8;@X'!K5TNWDL-)@LI+=F*(5<J5PQ.<GK7'.'M*^NT5^9R2C[2MKLE^
M9YO8NUO=V]S\NV.9<LW0<YY_(UTWB>XM]8O=+@M9E:.1F F'(R2!TZ\8J#Q'
MI4&F:;"MM!,B/.68R,&Q\N .*S_#,,DVO6S(I<0DR,H;''3C\Q7 HR@_8/K8
MXTI0?L7UL=_I5B=-TR&S,@<Q@@L!@'DGI5RH?.D_Y]I?S7_&CSI/^?:7\U_Q
MKVDE%61ZR22LB:BH?.D_Y]I?S7_&CSI/^?:7\U_QIC)J*A\Z3_GVE_-?\:/.
MD_Y]I?S7_&@":J>K G1KT $GR'X'TJ;SI/\ GVE_-?\ &D:1F4JUM(01@C*\
MC\Z4E=-":NFCD/ T+?:[N<@A?*"@XX//_P!:NVJI:Q1V4 @MK%XH@20BE< G
MKWJ7SI/^?:7\U_QK*A3]G!1,Z-/V<%$FH@_Y"D'_ %RD_FE0^=)_S[2_FO\
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M1110 5%<_P#'I-_N-_*I:BN?^/2;_<;^5 &/I_\ R#+/_KA'_P"@BK%5]/\
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M3'_TT_[]-_A5%$U%0_:8_P#II_WZ;_"C[3'_ --/^_3?X4 345#]IC_Z:?\
M?IO\*/M,?_33_OTW^% $U%0_:8_^FG_?IO\ "C[3'_TT_P"_3?X4 345#]IC
M_P"FG_?IO\*/M,?_ $T_[]-_A0!-14/VF/\ Z:?]^F_PH^TQ_P#33_OTW^%
M$U%0_:8_^FG_ 'Z;_"C[3'_TT_[]-_A0!-14/VF/_II_WZ;_  H^TQ_]-/\
MOTW^% $U%0_:8_\ II_WZ;_"C[3'_P!-/^_3?X4 345#]IC_ .FG_?IO\*/M
M,?\ TT_[]-_A0!-14/VF/_II_P!^F_PH^TQ_]-/^_3?X4 345#]IC_Z:?]^F
M_P */M,?_33_ +]-_A0!-14/VF/_ *:?]^F_PH^TQ_\ 33_OTW^% $U%0_:8
M_P#II_WZ;_"C[3'_ --/^_3?X4 345#]IC_Z:?\ ?IO\*/M,?_33_OTW^% $
MU%0_:8_^FG_?IO\ "C[3'_TT_P"_3?X4 340?\A2#_KE)_-*A^TQ_P#33_OT
MW^%/M)5DU6$+NXBDZH1W7U% &Q1110 4444 %17%O%=1>7,FY<YZX(/J".E2
MT4 5AI]H)HI1 H>(;4([#Z?B?SIGV.WL[.Y$$03>I)P2>W\O:KE17/\ QZ3?
M[C?RH Q]/_Y!EG_UPC_]!%6*KZ?_ ,@RS_ZX1_\ H(JQ0 4444 %%%% !111
M0 4444 %%%% !114=Q/':VTMQ*<1QJ68^PH;MJ&Q%<:A9VDL<5Q<QQ22?<5F
MP3VI[W=M'*T3W$2R*"Q0N,@>N*\XO[Z^UR]DO5B8K;C< B_ZI,Y!-,2QU/6?
M,OTBDN)'EVNR@9)QU_E7G/&MMJ,;]O0X'BVW:,;G9:IXIL+6R9K2X2XN&!$8
MC.=I]3[5S5AX6O=2MX+SSXO*F)+DL=P&>3TY/6KFF^$+A;^V>]B5K;;NE3>,
MAN<+[CI79P6\-K"L,$:QQ+T51@"G&E.N^:LK)=!QIRK.]5678JZ3IJZ38+:)
M*TJABVYE ZU8GM+:Z93<6\4I484R(&Q^=345W**2Y;:'8HI+EZ#8XTAC6.)%
M2-1A548 %.HHJB@KC_%'AY6^UZLL^%" F()WX'6NPJ&[MQ=V<ULS%5E0H6 Y
M&:RK4U4@TS*K352-F>?Z;8WOB*^2615>"$HDF3M4*!C  [X':O0+:TMK-"EM
M D2G&0@QG'KZU7TO2[?2;000C)_CD(P7/J:O5GAZ/LXW>[(H4>17>Y'+;P3L
MC2PQR-&<H64$J?4>E2445TV.@**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *(/^0I!_P!<I/YI11!_R%(/^N4G\TH U:*** "BBB@ HHHH *BN?^/2;_<;
M^52U%<#-M*/]@_RH Q[#C2[0G@"WCY/^Z*L8)[5YS)K-YX@M;#3((1%\BC:K
M9WD+QG\C4*_VX(VTP1W?#!O+ ;*8]#V'/TKA>,5_=BVOU.-XM7T5T>FX/H:8
MDD<F[8ZOM.&VL#@^AKSVXL/$5E;?:Y)+I0W#!9267GC(!J"T_M;21#?(TD$5
MQ-L.[^(]]RG\>:3QC3LX-">*:>L6>ET5D:UKD.FV#36[P3S;PBIO!Y[GCTKG
M%\<WH(WVENPQS@L,FMZF)IP?+)FT\13@[-G=455TV]74=-@NU7;YBY*^AZ$?
MG1<:E8VDOE7%W#%)C=M=P#BMN:-N:^AKS*U[Z%JBH/MUI]H2W^TQ><ZAE3>,
MD'IBN:U+Q/=R:D++1HUE*$[F*[MY'7'M[U%2M""NV3.K&"NSK**X!?%6O20M
M-&J-$GRNZP9 )]34S>-[UX=D=I$)2H&_D_-W.W^E8+&TO/[C'ZW3\S>\2ZRV
ME6*BW9/M4K;5!Y*CN<5R]Q9^*;F*2.=;R1&QN0MP<^U7]"T>?6;I=9U*4NN_
M*KC!<J>,_P"R*[2H5.6(]Z3:71$<DJ_O2;2Z&;INB6>G6VQ(%,CQA)F))W^N
M:NV]M!:0B&VA2*,$G:@P,U+17;&$8Z)'6HQCL@HHHJB@HHHH **** "BBB@
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M\ML,6XXZ=,Y%=-+H^GR6CVWV2%4;.,(/E.,9'O5ZBLH4*<%9(SA1A!62//\
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M^_R_XT?VC8_\_P!:_P#?Y?\ &@"S15;^T;'_ )_K7_O\O^-']HV/_/\ 6O\
MW^7_ !H LT56_M&Q_P"?ZU_[_+_C1_:-C_S_ %K_ -_E_P : +-%5O[1L?\
MG^M?^_R_XT?VC8_\_P!:_P#?Y?\ &@"S15;^T;'_ )_K7_O\O^-']HV/_/\
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M1_:-C_S_ %K_ -_E_P : +-%5O[1L?\ G^M?^_R_XT?VC8_\_P!:_P#?Y?\
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M48GCGA0A;>1MA;ISG:,8STXS6793:A-+&\\ENERKPQ;%DB9)4PID8X^;.=^
M,=5XZULZ+)'+:.5L?L;>8P9/(,8(R=IY SE<?RK.MFT.UU1+.TMM/A,<SK('
M"K(DAP5V \D$D]/PH FUY[VW:/[(EN89$*2*[(I!+)\PW<'"[_Q(X-6M*1VB
MG5Y(YXDDVPR$HS%<#[VWCKG'MC--UH:6HMYM3M?-$3%HW\AG"'H<D XSG'/6
MET"Z@N],$L-O% =Y#I$FU0WY#/&* ,:UFU.21&GDMDNH_)B 62(I-P/,9OXN
MN< 8ZCCK6EX@:\M[=7L?)SM<&-BBEVXQR_&,;OQV]L@Y\%YH,%^L-AI\3;;E
MEEQ:/N5S@@I\O3<>3T')K:UB'3&MXI]3@2589%,>8R[!R=H  !)SG&.^: (=
M#$LD$OG,KQ!@(0YC:11@9#%/EZ],=JQA+JIOQ&TL/F*%"2J\'E,2QWAA]_&,
M8 &?7GFM[19$DLF9;'[&WF,&C$)C!YX/(&<C'\JSLZ%9ZJ;6&WT^*47&;@2[
M592R;@R ]<L5Z=R: +.OM>6]LLE@8 P5\H^Q2[8^49;C&>O([>X*Z$)7BE\T
MAH5VB)9&C:1>.0QC^7'I4VM+IOD1/J=L9HXY Z'R3)L8=^ <>GOG%-T&ZM+N
MUE>VMXH,2L&6./8",G:>@Y*X/MF@#$DFU47S1F6'S%7$<JO (MQ<Y# _/M V
M\ 9X/)ZUOZI%,8X/L]S%:*)?WLC*OW-K<#<,==OX9K'DO- MK^:.VL(WF%T?
MM(^R.6W%<Y3Y<$EMO3U)K<U6"PGTV;^TXT>TC'F/O&=NWG/KD8[4 1::&+2(
M\]A.B@;?L\>TCUR,FL^(7D7S3:GIKS[W&R:-?E!8X 92#TQU!Y%7-'EADENA
M%IWV0*X"'[,T7F)@8)RHYSNX_P :I7+:'9ZI)"+;3TN'F62Y-P%3A@?G7/4Y
M SCWH T-4BFS;&WNH;2,2'SG=5.1M.!R/[V/3I3M-#,LB22V$Z)@(;9-N/J,
MG%&LII[V0_M*V,\"N' $1?8PY#<#C'K_ (U!H%Y9W:W1M;:*#9)C]W'LW)SM
M)X'/7CM0!6"W<3NTFIZ:TPEDVQSQJ=BECM 8$$?+C.0>:T=4$J6!:V,<;AEW
M-\H.W/.TMQN],\5BWMWH5KJ5TL5A%+=^:KW0:U=L@@Y*_*0S<=NM;]_!9W6F
MS1W\2/:%-TBR#@ <Y]L=?;% &3H1NWNF2X>%XQ&Q=5:(KNW#:4"<@8SG=WQB
MJFH2:@MY)MFB&UGV;'A&TY_=_?YQC._OG&.,UIZ-/:S7-Q]FT[[/'A3%+]E:
M+S$P,Y)4=\\>V:K:@=$L]2E#VU@MY,8Y9C<[5#(6*E@3P6 !_2@"]J(N(]-B
M>-H4DROG,FU21CG86XSG&,]JIZ#]L>9UN7A>,1Y<*8R/,)Y*;.0G^]SFM'58
M["73&6^M_/M3@E5C+XQR" HR,=<]JJ:'>V%W/=K9VT4.QAM:.'873 Y/ YW;
MACVH S]1?4$OI )H@BLVP1/"I7^YC?R.^[/J,=ZU+XW46CQ2)Y'VCY/.9"JY
M'&[86XSZ9XK/U&YT*VU.Y!LH9+\^4T^^V9@R[L$Y"D%@H/N< 5L7D5C>:.XO
MH%^Q&+>Z2IC:H&>1V(_,8H R] 2[%Q(L]TD\#!W".8FD0EOE'[L =,YZ\XQW
MJOJ?VY]2*+="W6.8,C1O %\O;T(<%M^2?;ISUK2T>:VEN+G[/IQMD&/*D^RM
M%YB8'7*CG=GCT&:KZJ='M-0=I+:Q^WSHC%KD!5= V"<GC< 3[]* +=T;N/0X
MY%^S_:ML9E9"H4]-^PMQGKC/'3-4=!CN_M<@FNDGMWWN(Y&B:1.1M_U8 S][
M/7^'OFM6_2PGTATN(!<63H 8TC,@*]L!1]#D=.M4-$O=/N;^YBLK6*((H\MT
MA*LZX&<\#O0!4U87KZB8DN?LZ)*K1M&\ 79@;@P<%M_WL8XY'O5^[DN8/#:S
MO+:QW2I&99A@)U&XJ3QDC.,\9Q5/5[C1;;4YMUG!+JCQ*29;=BK*#@98*1D
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M)KFR6X5'S.5W1*P)'S8QG&,'&.<U!JM]IVG75S'MW7MU 7\IXW,<A4 #<0"
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M7 =YTCD,JEFSO4'J1G( K/%WINH:QI]KMF8V_P R2.KI)YB]%;(&1@L>>X%
M%G575-4A@EOX;6WDB.U-J'<^?XPP/RXQTQSGGI4^GR7<EK?M<_9//CGD6/#
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M7MRVL07%HC,)YXX8@K#("*>-PRQQQD'U[5K^(7:W2W,5_;VFYB&BDC4F88Z
MD'&/ICGG'6J\XL)I[/28K:>6WM90K2I')^Y92K(NX#!'0$$XP.:UM2DLK(PZ
MC=L8_*/E"0= '(&&]LA3^ H J>&_/DTP"_F$UV#EU:.-3&#RH(3C[N#^-8L-
MQ>'5X?\ B<P36L<C>?/'#"%"=E.?F'S8&1D'U'2MW0([7R;BY@,/F3RYF6";
MS$4@  #T^4 X]2:RKJ?29/L6C^3.(5E"D.DB/$!R@7C.,A1CIB@#1\0NUO!
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MU9X[2]AEE,8@BA4S,T$_S-G]WP#C!^8C[O7K75BRB%^;TEVFV>6NYB0BD@G
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C %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %# @(# 2(  A$! Q$!_\0
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M*C_YYK^5'DI_=_6CR4_N_K0 >5'_ ,\U_*CRH_\ GFOY4>2G]W]:/)3^[^M
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M_NBGTR+_ %*?[HI] $<\$=S;RP2KNCE0HP]01@USY\$:2RN)'NG\P REI?\
M6,,A7.!]Y<\8_6NDHH IVVF6UMIQLL-+$VXR&4[C(6)+%O<DFJ/AFVACT*.-
M(E5$FG55 X $SX%;59/AS_D##_KXN/\ T<] &GY,?]P4>3'_ '!3Z* &>3'_
M '!1Y,?]P4^B@!GDQ_W!1Y,?]P4^B@!GDQ_W!1Y,?]P4^B@!GDQ_W!1Y,?\
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MYB?WU_.CS$_OK^=+M7T'Y4;5]!^5 ">8G]]?SH\Q/[Z_G2[5]!^5&U?0?E0
MGF)_?7\Z/,3^^OYTNU?0?E1M7T'Y4 )YB?WU_.CS$_OK^=+M7T'Y4;5]!^5
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MRO$RV]I9F$EUQM9W#!?J<$UT4%:G*?5&<W>2B=Y\9HT@^&%RD*+&L<T.Q4&
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M&: *?@JV6UT#RE210)Y,%^C<]5^5>/P]:Z*N<\+ZC8CPN]Y&!%:PF1G/E!
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M/Y"C8W_/0_D*?10 S8W_ #T/Y"C8W_/0_D*?10 S8W_/0_D*-C?\]#^0I]%
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MH ?13/-_V'_[YH\W_8?_ +YH ?13/-_V'_[YH\W_ &'_ .^: 'T4SS?]A_\
MOFCS?]A_^^: 'T4SS?\ 8?\ [YH\W_8?_OF@!]%,\W_8?_OFCS?]A_\ OF@!
M]%,\W_8?_OFCS?\ 8?\ [YH ?13/-_V'_P"^:/-_V'_[YH ?13/-_P!A_P#O
MFCS?]A_^^: 'T5'YO^P__?-24 9TO^M?_>-%$O\ K7_WC10!>B_U*?[HK+\2
M6=]?Z2;?3TMVG9QGSY7C 7G)&WDGV/'K6I%_J4_W13Z ,GPWILFDZ+%9RH4=
M"20;AINIS]XJOY  "M:D9@JEF(  R2>U9J^(M)=5=;U&1H3.' )78,C<3C ^
MZ>OI0!IUD^'/^0,/^OBX_P#1SUH6EW!?6J7-M()(7SM8<=#@]>AS6?X<_P"0
M,/\ KXN/_1ST :U%%% !1110 4444 %%%% !1110 445#>7*65E/=2 E(8VD
M8#K@#)_E0!-17'#XE:$G@BT\571G@LKI_+2,INDWY(Q@'_9)^E<WKOQPT2U-
MW::5%-=7'D;K6X"@Q/(P&T$9W#!//';%:QHU).R1#G%;LP_BE\3[^VU\:#X=
MN9H);=GANF51^\9E 4*>H(R?3G%;OPZ\*RZK\/[+^V6NHKE-8;43O&'9T;'S
M9&>2#GZU=\ >$\:%-=>+M(MCK#ZC)=M+.BLQ.058'TZX%=%?^(Y8;S=;1^9:
M*3#NQ]^7MCV%;5*D8Q]G!;=2(P;?-(XWX@?"*X\5^(9M9LM22)IHXU>"53@E
M<#((_P!G/;K]:],L+.WTC3+6PA;;!:PK%'O;G:HP,GZ"N=@\1W.F130ZFC27
M6\,J<#"D9_2G_P!BWVN(+R_E6%V"^6B9P$[Y'J:PE4E**B]D:**3NB_<^*M,
M@V[)&F);!$8Z#UYKS+XH^'[#5]&N_'%C//::C8*B-&H"[OG W$CG=ANN>U>M
M66D6-@&$$"_,<Y89(]L^E<SKEK=Z?J\E[''YEJY65QCY..,-_GO13J.$N9!*
M*DK,XSP;X[C\+?!^5M0A:&ZT^=[."+;\SR,#(F0>GWNI["KO@S0;_1M1C\;^
M)-3^U:AJ=F1Y&S+*S$%0I' &T#CC&<5S-QI3ZK\2[FXU:W^U:;(@O&@ PC2[
M/+4,.XX.0.U>P:9H3,+:XOY%E"1@16X3"1=,8'L!6]6<4O=WEJ_\C.$6]^AS
M_B/[3K*V<5^8;2?3[Z'48T92WF(N?W?^\<BM&34M5LI8=4NP3#-E5M 2-HQD
M$UN:EHT&H3P3;466.169R.64?PUI$ ]0#]:Y6VTD:VZG**NM:NT<5P!%;7(W
MF14P43^[GWXKI;:SM[1 L$*1@ +E5Y(]S4_08%%(9F>((Q)H-V#GA-W'L<U2
M\);I+"XN9-QDEFY8]\ 8K8O[7[;83VP;:9$*AL=*9IMF;#3H+4OO,:X+ 8S0
M!;HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#.E_P!:_P#O&BB7_6O_ +QHH O1?ZE/]T4^F1?Z
ME/\ =%/H 1@2I"D!L<$C.#7)R>"WN+6*&XU%"\:N/.BMMCMEF8 G<<J"V=O?
M'6NMHH H66F+;::]I-*TK2L\DLBYCW,[%FQ@Y7D\<_C53PQ;QQZ%'&N_:DTZ
MC+L3@3/W)R:VJR?#G_(&'_7Q<?\ HYZ -/RE_P!K_OHT>4O^U_WT:>#D9%(S
M*BEF(50,DDX % #?*7_:_P"^C1Y2_P"U_P!]&ECD2:-9(G5T895E.01Z@TI8
M#J0* &^4O^U_WT:/*7_:_P"^C3P0>AS10 SRE_VO^^C1Y2_[7_?1I]0W%W;V
MB!KB9(E)P"[8S0 _RE_VO^^C1Y2_[7_?1K/?Q#I4<AC:]CW#TR1^8J&?Q/ID
M+;4E:9NF(ESS0!K>4O\ M?\ ?1KRWXPZIJ9MK3PUHL<YEOAYEU+&Y^2'.-I]
M 23^"FM34-2U/Q/KMQX?MXQ;M;0"XG1Y"J@,2$5BO))].@Q6GX<\*7%H\DNK
M+:R!D3RXD+.4/5@6;K@\#']:UA[C4F0_>T/(=.\"W,'BN*S1Y+_P\A>:."4Y
M.XH5QLZ;AG.>G%=%X:^'>G:;:P'^S;G4KJ.[2=+N0>6 R_=7'/R]SSSQTKV/
M[%;"Z%R($$X&T.!SBIZJ6(J2ZB5.*.;3PW+>M]HU2YD,Q<DI&V4QZ#/3BM3^
MQ;$6\4"1%(XI!*H#'[U:%%8&A3DTNRENOM,D"M+MV[CD\59\I?\ :_[Z-/HH
M 9Y2_P"U_P!]&FR6T,T;1R)O1NJL20:EHH Y^VT9U\3W%XZ;8 H\LCN2,?AC
M%;OE+_M?]]&GT4 ,\I?]K_OHT>4O^U_WT:?10 SRE_VO^^C1Y2_[7_?1I]%
M#/*7_:_[Z-'E+_M?]]&GT4 ,\I?]K_OHT>4O^U_WT:?10 SRE_VO^^C1Y2_[
M7_?1I]% #/*7_:_[Z-'E+_M?]]&GT4 ,\I?]K_OHT>4O^U_WT:?10 SRE_VO
M^^C1Y2_[7_?1I]% #/*7_:_[Z-'E+_M?]]&GT4 ,\I?]K_OHT>4O^U_WT:?1
M0 SRE_VO^^C1Y2_[7_?1I]% #/*7_:_[Z-'E+_M?]]&GT4 ,\I?]K_OHT>4O
M^U_WT:?10 SRE_VO^^C1Y2_[7_?1I]% #/*7_:_[Z-'E+_M?]]&GT4 ,\I?]
MK_OHT>4O^U_WT:?10 SRE_VO^^C1Y2_[7_?1I]% #/*3_:_[Z-/HHH SI?\
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MM #Z*9Y,?]W]:/)C_N_K0 ^BF>3'_=_6CR8_[OZT /HIGDQ_W?UH\F/^[^M
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MFQG'.,XS0!I44S=)_P \Q_WU1ND_YYC_ +ZH ?13-TG_ #S'_?5&Z3_GF/\
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M1ND_YYC_ +ZH ?13-TG_ #S'_?5&Z3_GF/\ OJ@!]%,W2?\ /,?]]4@>0_\
M++'_  *@"2BF;I/^>8_[ZHW2?\\Q_P!]4 /HIFZ3_GF/^^J-TG_/,?\ ?5 #
MZ*CWR9QY?_CU+ND_YYC_ +ZH ?13-TG_ #S'_?5&Z3_GF/\ OJ@!]%,W2?\
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M_P"%K>$?^?VY_P# *;_XFE'Q6\(D@?;;GG_IRF_^)KL\#T%&!Z"M+T^S^_\
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M)&B:?:JL3;XP(5 1O4<<'WJQ%!# "(8DC!QD(H&<#';V 'X4 24444 %%%%
M!1110 4444 %%%% &=+_ *U_]XT42_ZU_P#>-% "+<RA0 _ 'H*7[5-_?_04
M44 'VJ;^_P#H*/M4W]_]!110 ?:IO[_Z"C[5-_?_ $%%% !]JF_O_H*/M4W]
M_P#0444 'VJ;^_\ H*/M4W]_]!110 ?:IO[_ .@H^U3?W_T%%% !]JF_O_H*
M/M4W]_\ 0444 'VJ;^_^@H^U3?W_ -!110 ?:IO[_P"@H^U3?W_T%%% !]JF
M_O\ Z"C[5-_?_0444 'VJ;^_^@H^U3?W_P!!110 ?:IO[_Z"C[5-_?\ T%%%
M !]JF_O_ *"C[5-_?_0444 'VJ;^_P#H*/M4W]_]!110 ?:IO[_Z"C[5-_?_
M $%%% !]JF_O_H*/M4W]_P#0444 'VJ;^_\ H*/M4W]_]!110 ?:IO[_ .@H
M^U3?W_T%%% !]JF_O_H*/M4W]_\ 0444 'VJ;^_^@H^U3?W_ -!110 ?:IO[
M_P"@H^U3?W_T%%% !]JF_O\ Z"C[5-_?_0444 'VJ;^_^@H^U3?W_P!!110
M?:IO[_Z"C[5-_?\ T%%% !]JF_O_ *"C[5-_?_0444 'VJ;^_P#H*/M4W]_]
M!110 ?:IO[_Z"C[5-_?_ $%%% !]JF_O_H*/M4W]_P#0444 'VJ;^_\ H*/M
M4W]_]!110 ?:IO[_ .@H^U3?W_T%%% !]JF_O_H*/M4W]_\ 0444 'VJ;^_^
7@H^U3?W_ -!110! SL6))Y)HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %$ @(# 2(  A$! Q$!_\0
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MGZT>2GI^M !Y4?\ SS7\J/*C_P">:_E1Y*>GZT>2GI^M !Y4?_/-?RH\J/\
MYYK^5'DIZ?K3Z ,R15\U^!]XT4Z7_6O_ +QHH O1?ZE/]T4^F1?ZE/\ =%/H
M **** "LGPY_R!A_U\7'_HYZUJR?#G_(&'_7Q<?^CGH UJ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#.E_UK_[QHHE_UK_[QHH O1?ZE/\ =%/ID7^I3_=%
M/H **** "LGPY_R!A_U\7'_HYZUJR?#G_(&'_7Q<?^CGH UJ*** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/>MNLGPY_P @8?\ 7Q<?^CGH T]TG_//_P >HW2?\\__ !ZGT4 ,W2?\\_\
MQZC=)_SS_P#'J?10 S=)_P \_P#QZC=)_P \_P#QZGT4 ,W2?\\__'J-TG_/
M/_QZGT4 ,W2?\\__ !ZC=)_SS_\ 'J?10 S=)_SS_P#'J-TG_//_ ,>I]% #
M-TG_ #S_ /'J-TG_ #S_ /'J?10 S=)_SS_\>HW2?\\__'J?10 S=)_SS_\
M'J-TG_//_P >I]% #-TG_//_ ,>HW2?\\_\ QZGT4 ,W2?\ //\ \>HW2?\
M//\ \>I]% #-TG_//_QZC=)_SS_\>I]% #-TG_//_P >HW2?\\__ !ZGT4 ,
MW2?\\_\ QZC=)_SS_P#'J?10 S=)_P \_P#QZC=)_P \_P#QZGT4 ,W2?\\_
M_'J-TG_//_QZGT4 ,W2?\\__ !ZC=)_SS_\ 'J?10 S=)_SS_P#'J-TG_//_
M ,>I]% #-TG_ #S_ /'J-TG_ #S_ /'J?10 S=)_SS_\>HW2?\\__'J?10 S
M=)_SS_\ 'J-TG_//_P >I]% #-TG_//_ ,>HW2?\\_\ QZGT4 ,W2?\ //\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#(S(9D*L 3TY )YSR?6M.LGPY!;V^EE;:\BND,KDO"H6-6SRJJ"=H![9K6H
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$4 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %! ?X# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#WJ..,Q(2B
MYVCM3O*C_P">:_E1%_J4_P!T4^@""X>VM;:6XG\N.&)"[N1PJ@9)K&3Q1I#Y
M_=3#$(G(,'.TDA>.Y)' %;-Y:Q7UE/:3@F*:-HW ]",&L(^"[!D16N;GY"TB
ME5C4B0DG>"$&.OW?N^U &U936U]:)<0QX1LC#IM92#@@@]"""*G\J/\ YYK^
M558=+MXM--@^^:)MQD,A^9RQ+,3C')))XQ53PW&K>'[3=EL*P!9B3@,0.: -
M7RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\
MN_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4
M?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]:
M#RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\
MN_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4
M?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]:
M#RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\
MN_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4
M?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]:
M#RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\
MN_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4
M?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]:
M#RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\
MN_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4
M?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]:
M#RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\
MN_K1Y,?]W]: #RH_^>:_E1Y4?_/-?RH\F/\ N_K1Y,?]W]: #RH_^>:_E4%X
MB+",(H^;L*L*BI]T8J"]_P!2/]Z@":+_ %*?[HI],B_U*?[HI] !1535+J2Q
MTF\NX8O-EAA>1(_[Q ) KAO^$UU(1C$ML64K&Y:,$,&+;IU*L08TVCIP>Y%
M'HE97AK_ )%^U^C?^A&ETW499M#6\D4W+C> ;=?]<%8@,H)Z, #U[U#X8E+>
M'+-O*D&58X(Y'S'@T ;5%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\
M*@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9
M_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_I
MF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]
M%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9_P!,
MW_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4
M>9_TS?\ *@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S
M_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9_P!,W_*@
M!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_T
MS?\ *@!]%,\S_IF_Y4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!]%,\S_IF_
MY4>9_P!,W_*@!]%,\S_IF_Y4>9_TS?\ *@!C742W:6I;]ZZ%U&.PIE[_ *D?
M[U9R8F\6,^X_NK7&/JU:-[_J1_O4 31?ZE/]T4^F1?ZE/]T4^@ I-BC^$=,=
M.U*3@9/2F":(XQ(AR,CYAR* '@ # X%97AK_ )%^U^C?^A&M0$, 000>0167
MX:_Y%^U^C?\ H1H U:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M -\__7HQ)_?7_OG_ .O3Z* &8D_OK_WS_P#7HQ)_?7_OG_Z]/HH 9B3^^O\
MWS_]>C$G]]?^^?\ Z]/HH 9B3^^O_?/_ ->C$G]]?^^?_KT^B@!F)/[Z_P#?
M/_UZ,2?WU_[Y_P#KT^B@!F)/[Z_]\_\ UZ,2?WU_[Y_^O3Z* &8D_OK_ -\_
M_7HQ)_?7_OG_ .O3Z* &8D_OK_WS_P#7HQ)_?7_OG_Z]/HH 9B3^^O\ WS_]
M>C$G]]?^^?\ Z]/HH 9B3^^O_?/_ ->C$G]]?^^?_KT^B@!F)/[Z_P#?/_UZ
M,2?WU_[Y_P#KT^B@!F)/[Z_]\_\ UZ,2?WU_[Y_^O3Z* &8D_OK_ -\__7HQ
M)_?7_OG_ .O3Z* &8D_OK_WS_P#7HQ)_?7_OG_Z]/HH 9B3^^O\ WS_]>C$G
M]]?^^?\ Z]/HH 9B3^^O_?/_ ->C$G]]?^^?_KT^B@!F)/[Z_P#?/_UZ,2?W
MU_[Y_P#KT^B@!F)/[Z_]\_\ UZ,2?WU_[Y_^O3Z* &8D_OK_ -\__7HQ)_?7
M_OG_ .O3Z* &8D_OK_WS_P#7HQ)_?7_OG_Z]/HH 9B3^^O\ WS_]>C$G]]?^
M^?\ Z]/HH 9B3^^O_?/_ ->C$G]]?^^?_KT^B@!F)/[Z_P#?/_UZ,2?WU_[Y
M_P#KT^HKFXBM+>2>9ML:#+'% #L2?WU_[Y_^O1B3^^O_ 'S_ /7J"\U""QM5
MN)2WELRJ-HR3GI5J@"K>7/V*TDN)9$"H,\KU/8=:Y'0;&[U/5!J<C@*DI9BW
M)+>F/QK>U]$N7L+1V^26X&]0>HP:UHH(H%*Q1J@)R0HQDT .4,/O,#]!BH+W
M_4C_ 'JRI_$L</CBT\-"$,\]F]TTN_[F&  Q[\_E6K>_ZD?[U-IK<2=R:+_4
MI_NBGTR+_4I_NBJ.L:S;:);+/=!RKDJNT=6VD@?4XP/<TAEN\N5LK*>Z=79(
M8VD*H,D@#.![U@'QM8"*.3[/<,KA0#&4<"1MVR/(;&X[3TX'<BM:QNCJNGR&
M2&:TDW/%(A8;D8<'##CW!%4&\':.Y)>.9F;EF,[99\DB0\\N,G#=1F@#5L;U
M+ZR6Y"/%DLK))C*,I*L#@D<$$<&J7AHC_A'K7D=&_P#0C5R+3K6+3Q8^4)+?
M!#++\^_)R2V>I)R3FJ'AB&)?#EFJQH%4,  O &XT ;.1ZT9'K3/*C_N+^5'E
M1_W%_*@!^1ZT9'K3/*C_ +B_E1Y4?]Q?RH ?D>M&1ZTSRH_[B_E1Y4?]Q?RH
M ?D>M&1ZTSRH_P"XOY4>5'_<7\J 'Y'K1D>M,\J/^XOY4>5'_<7\J 'Y'K1D
M>M,\J/\ N+^5'E1_W%_*@!^1ZT9'K3/*C_N+^5'E1_W%_*@!^1ZT9'K3/*C_
M +B_E1Y4?]Q?RH ?D>M&1ZTSRH_[B_E1Y4?]Q?RH ?D>M&1ZTSRH_P"XOY4>
M5'_<7\J 'Y'K1D>M,\J/^XOY4>5'_<7\J 'Y'K1D>M,\J/\ N+^5'E1_W%_*
M@!^1ZT9'K3/*C_N+^5'E1_W%_*@!^1ZT9'K3/*C_ +B_E1Y4?]Q?RH ?D>M&
M1ZTSRH_[B_E1Y4?]Q?RH ?D>M&1ZTSRH_P"XOY4>5'_<7\J 'Y'K1D>M,\J/
M^XOY4>5'_<7\J 'Y'K1D>M,\J/\ N+^5'E1_W%_*@!^1ZT9'K3/*C_N+^5'E
M1_W%_*@!^1ZT9'K3/*C_ +B_E1Y4?]Q?RH ?D>M&1ZTSRH_[B_E1Y4?]Q?RH
M ?D>M&1ZTSRH_P"XOY4>5'_<7\J 'Y'K1D>M,\J/^XOY4>5'_<7\J 'Y'K1D
M>M,\J/\ N+^5'E1_W%_*@!^1ZT9'K3/*C_N+^55+BZAM]0M+0Q(3<;N>!MP/
MZT 7LCUK"\5S^7HDB*RY=U5AGG'7^E;+K#&C.ZH%4$DD=!7'6RQ:QXO=UVO;
MK\V,<, ,#C\: ,>2ZNKZ-8RQ(AA^;G.0N3D^_->D0R VT;DC[@)/X5@Q>'EL
MHM4.U)$EC(A'\2C!./S_ )5>TQHY/#L$Q0<0<Y'H/_K4 9>GK_;NO-JH)2"W
M(5$;J3@__KKII)8X8GEED5(T4LSL<!0.I)K(\-6,=OHT3G#--^\.1TSVKDOB
M5XITA?#VO>'H9E_M8P11^3M(SYK!1@]\ Y(':KA!SE9"D[*Y0\%^)+7Q?\7-
M9U&WMU$5I8?9H9<[MZB7[X..,@]*]-O?]2/]ZN-^&/@B?P3IVI071C>:>Z)2
M5#DM$  N?3G<<>]=E>_ZD?[U76<7/W=D3!.VI-%_J4_W161XEGEAM+98+JZ@
MEEN%11;+'ODX)*YD^4<#.?:M>+_4I_NBL_6],EU:UBM4G$47FAIOD5BR@' &
MY2.N.W3-8ED7AI_,TMV-W<W+>?(&:Y"[U(;!4[?E./4<5L5BZ=!J&GZ'<PI]
MCN+N)I/(CA'EQ_["D?P]LCWKET/B>*"/S1J3S^4Z2H,DH@D?,BLOR,Q7 "XS
MT(H ]"K*\-?\B_:_1O\ T(TNF27<6A(\L5Q-,N[8DI E9-QV;LX^;;C.:A\,
M2.?#EF3"RDJQ*DCCYCQ0!M44S>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W
M_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'T4
MS>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'T4S>__ #R;\Q1O
M?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,
MWO\ \\F_,4;W_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W
M_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'T4
MS>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'T4S>__ #R;\Q1O
M?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,
MWO\ \\F_,4;W_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W
M_P">3?F* 'T4S>__ #R;\Q1O?_GDWYB@!]%,WO\ \\F_,4;W_P">3?F* 'UQ
MU]?_ &GQ5;.(CY5I,(68<Y)./YUU<MQY,3RR(51 222.!7)3*H\.W%\%$<US
M/YZ'<,X#<?EG]: +6MZNU]:FRL%=I6F:-U0Y)5>O'H?Z5:T:R70+&[N+^6&&
M+=O,LC!0J ?Q$]*P_#<,@UV*25&+-$TJX(YSQG^=8_QG\2VL?@O4-(M[N'[<
MTL,=Q;EAO6-LMG'OM'YU=.#G)1)D^57/4#B6([2"&7@@\'-<5I5U(FE:OA\-
M' JJ"?3(Z5XEJ_Q.US6=#LM*5G\J""(S[%"EGB8DL"O.TKMR/:O8S#]FO+>$
M$NE\L3OD8."V[%:5:$J27-U)A44MC;UKQ%;>#? PU.[4GR842.,=7D(PJ_GU
M]LUXO\/?"6N^,?&$?BK4#$T%O?[[HSDAV=0&VA<=LK^5=WXZUJQU7XA>&?"<
MEJTSPWL=U,IP4(VMA2/R/IBO38D6$,(K81AF+-M &3ZGWJXS=*GHM9?D)QYY
M>2)ZK7O^I'^]4ZL3U0K]34%[_J1_O5RFI-%_J4_W15'6$NWMXOLM^EBHD!FF
M(4D)@\#<".NW\,U>B_U*?[HK/\1,Z>'[QD\K(3GS75%VY&<LP*CC/)% #M'M
M[R&"9[\6WVF29F+VZX#+T4GOG'KGZFM&L/PK;V$.C*VG*5A=CQ]J\\9!P<')
M ^@K1_M73N/]/M>4:0?OEY5?O-UZ#!R>V* +=97AK_D7[7Z-_P"A&M*&:*XA
M2:&1)8G&Y71@RL/4$=:S?#7_ "+]K]&_]"- &K1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %9.M:VFE1+L5)92VTIOP
M5XSDBM4D*I8\ #)KB[&S;Q%K$][,JFVW%& ."!CY<?I0!9FU4Z]ID5N4,3R7
M*1,J-G<,9)KSKQCKUL_Q(\/:)I5UYB:<);:=67[KN,,,GKP.W2N^F^RZ-XIE
MG<K;V-O"9I&)^5!LY)KRNYTBT;P7JOQ!%K(\MQK2W5NLO!^SB;&/;<2<_05T
MX>*;;?I\V95&>ISW]GX6\/)XCU"952*R\N.,Y&]SDJH/J>E>6^!K%_B1\4KS
MQ)?V!&G1YD=&PZ;MH58R2.>,G\*Q?"[7?Q%\1Q>'+Z:>/2Y+FXOV$+?-&2.!
MSD8' ''&3ZU] ^%_"&F>$8KV/31)MNY_.<.V<'& !CH!6K2P\7'[3_(E-U&G
MT/-3\)8M$B\973KNMFLI/[-D#;F0%2S KCJ"  ?2MFTOS>:/X;U$2[F?3H6,
MA_O*,$_F*]+N8S-:S1KU=&49]Q7S]X1UF1_!NM-<J\D>C63QPQ;L8(7G'MN;
M-9WE5C=]&O\ (JR@]#JO@IX=\S3;GQ/JMLTNHW-PWV:XG&6$>.64GH"2WY5Z
MY7.^ H1;^ - C':QB/XE03_.NBK*M)RFV5!6B@JM>_ZD?[U6:K7O^I'^]619
M-%_J4_W15#7TBDT*[6=4:()E@Z[EX(/(W+G\Q5^+_4I_NBLOQ.%?P[=HT+3E
M@ D2RB,LVX$88@XYYZ'I0!0\,VHN/"+V\,OD"5I56>!LM@D@/RSX;V).*RAX
M!NXX1 FH0/&D@F4O!M(9&<JF%P-A#\]^*Z+PM=2WFA1330R1,68 .^XD GG.
MU?Y"MF@#/L=.DM])^R//LE8N[/ -NUF8L0N<\#.!FJWAB(KX<LU,LC$*PR2,
MGYCR>*V:RO#7_(OVOT;_ -"- &EY9_YZ/^E'EG_GH_Z4^B@!GEG_ )Z/^E'E
MG_GH_P"E/HH 9Y9_YZ/^E'EG_GH_Z4^B@!GEG_GH_P"E'EG_ )Z/^E/HH 9Y
M9_YZ/^E'EG_GH_Z4^B@!GEG_ )Z/^E'EG_GH_P"E/HH 9Y9_YZ/^E'EG_GH_
MZ4^B@!GEG_GH_P"E'EG_ )Z/^E/HH 9Y9_YZ/^E'EG_GH_Z4^B@!GEG_ )Z/
M^E'EG_GH_P"E/HH 9Y9_YZ/^E'EG_GH_Z4^B@!GEG_GH_P"E'EG_ )Z/^E/H
MH 9Y9_YZ/^E'EG_GH_Z4^B@!GEG_ )Z/^E'EG_GH_P"E/HH 9Y9_YZ/^E'EG
M_GH_Z4^B@!GEG_GH_P"E'EG_ )Z/^E/HH 9Y9_YZ/^E'EG_GH_Z4^B@!GEG_
M )Z/^E4[C4;2UNX[::Z*R/GJ1A>,\^F:G-];+?+9&4?:&7<$]J\V\5:D8_%,
MRR6[+:DA'NF($:/CY5)/<X/Y>]-)O83=CT.POH-2B>2WED(1BC!AC!JWY9_Y
MZ/\ I7*^"I5(NXLY)*L.>,<BNMI#&>6?^>C_ *4>6?\ GH_Z4^B@!GEG_GH_
MZ4>6?^>C_I3Z* &>6?\ GH_Z4>6?^>C_ *4^B@!GEG_GH_Z4>6?^>C_I5$:O
M#_;1TPHXEV[@W8\9K05U<95@P]0<T <YXFU*XL!#%;.V6!=R1GY1QBO+O&_C
MV]\/2P:%X>:6'4K-EFNYHE5XY5,9)4CD_+D9SZ5V6M>+K#2+C[?KA5(+H/;6
M2[-P)#<EAZ#C)K ^#O@M7MQXMU2,/>7$CRVDBR$YC==K;EZ=<UTT8QBG4FM.
MGF93;;Y8G/QZ_JGCO1(M#U=BFK76JPV<BVZ^7(UNJEW+CIQUZ5Z%XO\ #=MH
M_P &M1T:!I9X+.R/EF4@L2IW G '.:PSH]X_[1_VR*W)MDLQ/)(!@ &,H#[G
M<,5ZEJ5A%JFEW>GSY\JYA:%RO4!@1D>_-74FDX\NVXHQ;3OZ'CWPO\,7,'B'
M1M9ALFALGT(&6<#"R2LY&/\ >P :]H\L_P#/1_TJKI&F0:-H]GIEL6,%I"L*
M%NI"C&3[U=K"K4YY7+A'E5AGEG_GH_Z5\Y>(-%_X1'QE-X4@O)Y[7Q!Y G<X
M4QAY_F  Z\#%?2%>$?%*+9\9O#$AZ2?9OTF-;85^\UY?D15VN>X06J6UO%!"
MS+'$@1%&. !@5)Y9_P">C_I3Z*Y#8:J[?XF/UJ"]_P!2/]ZK-5KW_4C_ 'J
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M@!GG1_WQ1YT?]\4^B@!GG1_WQ1YT?]\4^B@!GG1_WQ1YT?\ ?%/HH 9YT?\
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M!)HF#1NH92.XH 7S4]_^^31YJ>__ 'R:?6?JVLVFD6KRSR+N XCSR?\  >]
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MGFI[_P#?)H\U/?\ [Y-/HH 9YJ>__?)H\U/?_ODT^B@!GFI[_P#?)H\U/?\
M[Y-/HH :KANF?RJ"]_U(_P!ZK-5KW_4C_>H FB_U*?[HK.U_2I]8TX6L%Z+0
M[PS/Y(DRO.1R1C/J.:T8O]2G^Z*?0!GZ+IBZ/I45BOD;8\X\B'REY.?NY//J
M<\UH4R7_ %+\.WRGA#AC]#QS7"-I.N/;VK1VMZ)A:"&=)KA?NAFR$<2$[V!
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M #Z*9MD_YZ?^.T;9/^>G_CM #Z*C*RXXD&?]VEVR?\]/_': 'T4S;)_ST_\
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MC)V\<C!XK4HHH 1CM4L<X SP,UQEKK'B993%]@ED0VDLJO/;L#YFXE <8'3
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M0^282Z91F5W^7D;^H/0#;G%=[10!R4M_XEAUEW%J9;0I.$C6(@ JY$0)S_&
M#NZ#(XYR)M'O-=O+BT_M$^5%-;R^8L5K(F'##&68 H<'H1@XX-=/10!PLESX
MGTG3KIK5+FZ9,-&+F)I79C)(,97G:%1. #]_)JY=:GX@.IQ^3;2B))U62,6K
M$+$4Y??G#D$_=&",=^_744 <OIFH^([N:-;JUBMU:\99/W#DQQ!6.,G .2%
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%10!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Nov. 04, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000831001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">Citigroup Inc<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-270327<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">S-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Offerings<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=1', window );">Offering: 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_Rule457rFlg', window );">Rule 457(r)</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Debt<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">1,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">1,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 1,777,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 245.40<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingAxis=2', window );">Offering: 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTable', window );"><strong>Offering:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_PrevslyPdFlg', window );">Fee Previously Paid</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesOthrRuleFlg', window );">Other Rule</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTp', window );">Security Type</a></td>
<td class="text">Other<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingSctyTitl', window );">Security Class Title</a></td>
<td class="text">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_AmtSctiesRegd', window );">Amount Registered | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxOfferingPricPerScty', window );">Proposed Maximum Offering Price per Unit</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_MaxAggtOfferingPric', window );">Maximum Aggregate Offering Price</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeRate', window );">Fee Rate</a></td>
<td class="nump">0.01381%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeAmt', window );">Amount of Registration Fee</a></td>
<td class="nump">$ 0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingNote', window );">Offering Note</a></td>
<td class="text">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_AmtSctiesRegd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of securities being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_AmtSctiesRegd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total amount of registration fee (amount due after offsets).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesOthrRuleFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesOthrRuleFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum aggregate offering price for the offering that is being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_MaxOfferingPricPerScty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum offering price per share/unit being registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_MaxOfferingPricPerScty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegativeDecimal4lItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingNote">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingNote</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTitl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The title of the class of securities being registered (for each class being registered).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTitl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingSctyTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Type of securities: "Asset-backed Securities", "ADRs/ADSs", "Debt", "Debt Convertible into Equity", "Equity", "Face Amount Certificates", "Limited Partnership Interests", "Mortgage Backed Securities", "Non-Convertible Debt", "Unallocated (Universal) Shelf", "Exchange Traded Vehicle Securities", "Other"</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingSctyTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:securityTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_PrevslyPdFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_PrevslyPdFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_Rule457rFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 457<br> -Subsection r<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_Rule457rFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Nov. 04, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOfferingAmt', window );">Total Offering</a></td>
<td class="nump">$ 1,777,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlPrevslyPdAmt', window );">Previously Paid Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlFeeAmt', window );">Total Fee Amount</a></td>
<td class="nump">245.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_TtlOffsetAmt', window );">Total Offset Amount</a></td>
<td class="nump">0.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NetFeeAmt', window );">Net Fee</a></td>
<td class="nump">245.40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 1,777,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NetFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NetFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlFeeAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlFeeAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOfferingAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOfferingAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlOffsetAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlOffsetAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_TtlPrevslyPdAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_TtlPrevslyPdAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative1TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="dp236936_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dp236936_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995211 - Document - Offerings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesOfferingTable</Role>
      <ShortName>Offerings</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dp236936_exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="dp236936_exfilingfees.htm">dp236936_exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="31">http://xbrl.sec.gov/ffd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dp236936_exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "dp236936_exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 0,
   "hidden": {
    "total": 4,
    "http://xbrl.sec.gov/dei/2024": 1,
    "http://xbrl.sec.gov/ffd/2024": 3
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 1,
   "elementCount": 107,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2024": 31,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236936_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236936_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
     "longName": "995211 - Document - Offerings",
     "shortName": "Offerings",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236936_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_offering_1",
      "name": "ffd:PrevslyPdFlg",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236936_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236936_exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c_report",
      "name": "ffd:TtlOfferingAmt",
      "unitRef": "USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dp236936_exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee prevoiusly paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2024",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0000950103-25-014290-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950103-25-014290-xbrl.zip
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M!FUZT<)/GG5#JZ-/SH5Z^=E[^//Q#PXX'_#3G?Q_.O\T,]]X?JR_-.I-C]C
MUV5O:%;5CU^NZK1]]=#];)=>2/S=#Q?J*ID_7>8C>4DGJQ;,3B=OF&JGA$^(
MEC5(L=,^*16*V"@5 CP] :X$[N3P<Z4GA%?.9(;#87J83;NLF]%*I5)F)&&4
M *@\LJCSLAQ4SD:@;6;1&5 YX@/KJIK-4(<+[!@D#F].7X@#%S+!9 A*N9O3
MM>(JY %$],)H&:PF&0&VR=/%W?447"R&GX)F!,,.EXZ+!?BCQ)1/J7I*+\20
MI#@Q9A#!<[KK#M;B.4EEM1#/*XW/2BJGVYA':C3)G Y#FC"1D1$@!.QTS,6
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<97,N:'1M4$L%!@     !  $ 1P   (8+      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>dp236936_exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2024/ffd-2024.xsd"
      xlink:type="simple"/>
    <context id="c_offering_1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>1</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_offering_2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
            <segment>
                <xbrldi:typedMember dimension="ffd:OfferingAxis">
                    <dei:lineNo>2</dei:lineNo>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <context id="c_report">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000831001</identifier>
        </entity>
        <period>
            <startDate>2025-11-04</startDate>
            <endDate>2025-11-04</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="pure">
        <measure>pure</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <ffd:SubmissnTp contextRef="c_report" id="ixv-211">424B2</ffd:SubmissnTp>
    <ffd:FeeExhibitTp contextRef="c_report" id="ixv-212">EX-FILING FEES</ffd:FeeExhibitTp>
    <dei:EntityCentralIndexKey contextRef="c_report" id="ixv-213">0000831001</dei:EntityCentralIndexKey>
    <ffd:RegnFileNb contextRef="c_report" id="ixv-214">333-270327</ffd:RegnFileNb>
    <ffd:FormTp contextRef="c_report" id="ixv-248">S-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c_report" id="ixv-249">Citigroup Inc</dei:EntityRegistrantName>
    <ffd:PrevslyPdFlg contextRef="c_offering_1" id="ixv-250">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_1" id="ixv-251">Debt</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_1" id="ixv-252">Citigroup Global Markets Holdings Inc. Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:Rule457rFlg contextRef="c_offering_1" id="ixv-253">true</ffd:Rule457rFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_1"
      decimals="0"
      id="ixv-254"
      unitRef="shares">1777</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-255"
      unitRef="USD">1000</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-256"
      unitRef="USD">1777000</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-257"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_1"
      decimals="INF"
      id="ixv-258"
      unitRef="USD">245.40</ffd:FeeAmt>
    <ffd:PrevslyPdFlg contextRef="c_offering_2" id="ixv-259">false</ffd:PrevslyPdFlg>
    <ffd:OfferingSctyTp contextRef="c_offering_2" id="ixv-260">Other</ffd:OfferingSctyTp>
    <ffd:OfferingSctyTitl contextRef="c_offering_2" id="ixv-261">Citigroup Inc. Guarantee of Medium-Term Senior Notes, Series N</ffd:OfferingSctyTitl>
    <ffd:FeesOthrRuleFlg contextRef="c_offering_2" id="ixv-262">true</ffd:FeesOthrRuleFlg>
    <ffd:AmtSctiesRegd
      contextRef="c_offering_2"
      decimals="0"
      id="ixv-263"
      unitRef="shares">0</ffd:AmtSctiesRegd>
    <ffd:MaxOfferingPricPerScty
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-264"
      unitRef="USD">0.00</ffd:MaxOfferingPricPerScty>
    <ffd:MaxAggtOfferingPric
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-265"
      unitRef="USD">0.00</ffd:MaxAggtOfferingPric>
    <ffd:FeeRate
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-266"
      unitRef="pure">0.0001381</ffd:FeeRate>
    <ffd:FeeAmt
      contextRef="c_offering_2"
      decimals="INF"
      id="ixv-267"
      unitRef="USD">0.00</ffd:FeeAmt>
    <ffd:TtlOfferingAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-268"
      unitRef="USD">1777000</ffd:TtlOfferingAmt>
    <ffd:TtlFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-269"
      unitRef="USD">245.40</ffd:TtlFeeAmt>
    <ffd:TtlPrevslyPdAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-270"
      unitRef="USD">0.00</ffd:TtlPrevslyPdAmt>
    <ffd:TtlOffsetAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-271"
      unitRef="USD">0.00</ffd:TtlOffsetAmt>
    <ffd:NetFeeAmt
      contextRef="c_report"
      decimals="INF"
      id="ixv-272"
      unitRef="USD">245.40</ffd:NetFeeAmt>
    <ffd:OfferingNote contextRef="c_offering_1" id="ixv-273">The filing fee paid with this filing pursuant to Rule 457(r) under the Securities Act of 1933, as amended (the "Securities Act"), was originally deferred in accordance with Rule 456(b) under the
Securities Act.</ffd:OfferingNote>
    <ffd:OfferingNote contextRef="c_offering_2" id="ixv-274">No separate consideration will be received for the guarantee, and pursuant to Rule 457(n) under the Securities Act, no separate registration fee is payable.</ffd:OfferingNote>
    <ffd:NrrtvMaxAggtOfferingPric
      contextRef="c_report"
      decimals="INF"
      id="ixv-275"
      unitRef="USD">1777000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c_report" id="ixv-276">true</ffd:FnlPrspctsFlg>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
